Triller (ILLR) 10-Q 15 May 23 2023 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 12, 2023
Document Information Line Items
Entity Registrant Name	AGBA Group Holding Ltd.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		62,850,898
Amendment Flag	false
Entity Central Index Key	0001769624
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-38909
Entity Incorporation, State or Country Code	D8
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	AGBA Tower
Entity Address, Address Line Two	68 Johnston Road
Entity Address, City or Town	Wan Chai
Entity Address, Country	HK
Entity Address, Postal Zip Code	N/A
City Area Code	+852
Local Phone Number	3601 8000
Entity Interactive Data Current	Yes
Ordinary Shares
Document Information Line Items
Trading Symbol	AGBA
Title of 12(b) Security	Ordinary Shares
Security Exchange Name	NASDAQ
Warrants
Document Information Line Items
Trading Symbol	AGBAW
Title of 12(b) Security	Warrants
Security Exchange Name	NASDAQ

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 3,653,778	$ 6,449,876
Restricted cash	44,982,294	44,844,196
Accounts receivable, net	3,203,410	2,822,162
Accounts receivable, net, related parties	359,488	272,546
Loans receivables	517,376	517,479
Income tax recoverable	423,407	260,120
Deposit, prepayments, and other receivables	1,105,649	589,786
Total current assets	54,245,402	55,756,165
Non-current assets:
Loans receivables	1,062,774	1,072,392
Property and equipment, net	7,222,567	7,359,416
Notes receivables	588,858
Long-term investments, net	34,545,838	37,033,360
Total non-current assets	43,420,037	45,465,168
TOTAL ASSETS	97,665,439	101,221,333
Current liabilities:
Accounts payable and accrued liabilities	17,501,963	20,274,429
Escrow liabilities	29,463,549	29,487,616
Borrowings	6,251,749	4,477,254
Amount due to shareholder	4,973,844	6,289,743
Forward share purchase liability	13,573,788	13,491,606
Income tax payable and provision	23,000,000	23,000,000
Total current liabilities	94,764,893	97,020,648
Long-term liabilities:
Warrant liabilities	3,868	4,548
Deferred tax liabilities	45,613	45,858
Total long-term liabilities	49,481	50,406
TOTAL LIABILITIES	94,814,374	97,071,054
Commitments and contingencies
Shareholders’ equity:
Ordinary shares, $0.001 par value; 200,000,000 shares authorized, 61,750,898 and 58,376,985 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	61,751	58,377
Ordinary shares to be issued	1,665	1,665
Additional paid-in capital	54,773,534	43,870,308
Accumulated other comprehensive loss	(518,142)	(384,938)
Accumulated deficit	(51,467,743)	(39,395,133)
Total shareholders’ equity	2,851,065	4,150,279
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 97,665,439	$ 101,221,333

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Ordinary shares, par value (in Dollars per share)	$ 0.001	$ 0.001
Ordinary shares, shares authorized	200,000,000	200,000,000
Ordinary shares, shares issued	61,750,898	58,376,985
Ordinary shares, shares outstanding	61,750,898	58,376,985

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Interest income:
Loans	$ 38,158	$ 61,323
Total interest income	38,158	61,323
Non-interest income:
Commissions	10,015,627	827,077
Recurring service fees	780,962	947,980
Total non-interest income	10,796,589	1,775,057
Total revenues from others	10,834,747	1,836,380
Non-interest income:
Recurring service fees	238,933	239,943
Total revenues from related parties	238,933	239,943
Total revenues	11,073,680	2,076,323
Operating cost and expenses:
Interest expense	(165,096)
Commission expense	(7,295,492)	(701,042)
Sales and marketing expense	(1,856,903)	(240,351)
Technology expense	(878,986)	(133,867)
Personnel and benefit expense	(9,605,190)	(2,004,979)
Other general and administrative expenses	(5,855,821)	(908,401)
Total operating cost and expenses	(25,657,488)	(3,988,640)
Loss from operations	(14,583,808)	(1,912,317)
Other income (expense):
Bank interest income	170,526	7,639
Foreign exchange gain (loss), net	556,311	(480,574)
Investment (loss) income, net	1,723,064	2,148,935
Change in fair value of warrant liabilities	680
Change in fair value of forward share purchase liability	(82,182)
Rental income	59,507	79,067
Sundry income	56,644	129,353
Total other income, net	2,484,550	1,884,420
Loss before income taxes	(12,099,258)	(27,897)
Income tax benefit (expense)	26,648	(419,497)
NET LOSS	(12,072,610)	(447,394)
Other comprehensive loss:
Foreign currency translation adjustment	(133,204)	(274,351)
COMPREHENSIVE LOSS	$ (12,205,814)	$ (721,745)
Weighted average number of ordinary shares outstanding – basic and diluted (in Shares)	60,670,198	55,500,000
Net loss per ordinary share – basic and diluted (in Dollars per share)	$ (0.2)	$ (0.01)

Unaudited Condensed Consolida_4

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Weighted average number of ordinary shares outstanding diluted	60,670,198	55,500,000
Net loss per ordinary share diluted	$ (0.20)	$ (0.01)

Unaudited Condensed Consolida_5

Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)	Ordinary shares	Ordinary shares to be issued	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit	Receivable from the shareholder	Total
Balance at Dec. 31, 2021	$ 53,835	$ 1,665	$ 38,706,226	$ (179,461)	$ 52,125,502	$ (29,562,195)	$ 61,145,572
Balance (in Shares) at Dec. 31, 2021	53,835,000	1,665,000
Special dividend to the shareholder					(47,000,000)	29,562,195	(17,437,805)
Foreign currency translation adjustment				(274,351)			(274,351)
Net income (loss)					(447,394)		(447,394)
Balance at Mar. 31, 2022	$ 53,835	$ 1,665	38,706,226	(453,812)	4,678,108		42,986,022
Balance (in Shares) at Mar. 31, 2022	53,835,000	1,665,000
Balance at Dec. 31, 2022	$ 58,377	$ 1,665	43,870,308	(384,938)	(39,395,133)		4,150,279
Balance (in Shares) at Dec. 31, 2022	58,376,985	1,665,000
Issuance of ordinary shares to settle finder fee	$ 2,174		3,997,826				4,000,000
Issuance of ordinary shares to settle finder fee (in Shares)	2,173,913
Share-based compensation	$ 1,200		3,905,400				3,906,600
Share-based compensation (in Shares)	1,200,000
Forgiveness of amount due to shareholder			3,000,000				3,000,000
Foreign currency translation adjustment				(133,204)			(133,204)
Net income (loss)					(12,072,610)		(12,072,610)
Balance at Mar. 31, 2023	$ 61,751	$ 1,665	$ 54,773,534	$ (518,142)	$ (51,467,743)		$ 2,851,065
Balance (in Shares) at Mar. 31, 2023	61,750,898	1,665,000

Unaudited Condensed Consolida_6

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (12,072,610)	$ (447,394)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities
Share-based compensation expense	3,906,600
Depreciation of property and equipment	101,172	96,679
Foreign exchange (gain) loss, net	(556,311)	480,574
Investment income, net	(1,723,064)	(2,148,935)
Change in fair value of warrant liabilities	(680)
Change in fair value of forward share purchase liability	82,182
Change in operating assets and liabilities:
Accounts receivable	(468,190)	(35,008)
Loans receivables	9,721	2,314,813
Deposits, prepayments, and other receivables	(515,863)	(58,818)
Accounts payable and accrued liabilities	1,227,534	(1,017,905)
Escrow liabilities	(24,067)	1,727,504
Income tax payable	(163,287)	419,162
Net cash (used in) provided by operating activities	(10,196,863)	1,330,672
Cash flows from investing activities:
Proceeds from sale of investments	3,969,764	1,861,348
Purchase of notes receivables	(589,086)
Dividend received from long-term investments	608,714
Purchase of property and equipment		(864,542)
Payment of earnest deposit, the shareholder		(7,849,676)
Net cash provided by (used in) investing activities	3,989,392	(6,852,870)
Cash flows from financing activities:
Advances from the shareholder	1,684,101	2,912,956
Proceeds from borrowings	1,783,521
Dividend paid to the shareholder		(17,437,805)
Net cash provided by (used in) financing activities	3,467,622	(14,524,849)
Effect on exchange rate change on cash, cash equivalents and restricted cash	81,849	(100,353)
Net change in cash, cash equivalent and restricted cash	(2,658,000)	(20,147,400)
BEGINNING OF PERIOD	51,294,072	73,081,407
END OF PERIOD	48,636,072	52,934,007
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes	128,816
Cash paid for interest	165,096
Reconciliation to amounts on condensed consolidated balance sheets:
Cash and cash equivalents	3,653,778	16,720,706
Restricted cash	44,982,294	36,213,301
Total cash, cash equivalents and restricted cash	48,636,072	52,934,007
SUPPLEMENTAL DISCLOSURE OF NON CASH INVESTING AND FINANCING ACTIVITIES
Issuance of ordinary shares to settle finder fee	4,000,000
Forgiveness of amount due to shareholder	3,000,000
Purchase of property and equipment, through earnest deposit		7,205,118
Special dividend to the Shareholder offset with amount due from the shareholder		$ 29,562,195

Nature of Business and Basis of

Nature of Business and Basis of Presentation	3 Months Ended
	Mar. 31, 2023
Nature of Business and Basis of Presentation [Abstract]
NATURE OF BUSINESS AND BASIS OF PRESENTATION	NOTE 1 － AGBA Group Holding Limited (“AGBA” or the “Company”) was incorporated on October 8, 2018 in British Virgin Islands. The Company, through its subsidiaries, is operating a wealth and health platform, offering a wide range of financial service and products, covering life insurance, pensions, property-casualty insurance, stock brokerage, mutual funds, lending, and real estate in overseas. AGBA is also engaged in financial technology business and financial investments, managing an ensemble of fintech investments and healthcare investment and operating a health and wealth management platform with a broad spectrum of services and value-added information in health, insurance, investments and social sharing. The accompanying unaudited condensed consolidated financial statements of the Company are presented in United State dollars (“US$” or “$”) and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities Exchange Commission. Certain information and footnote disclosures normally included in consolidated financial statements have been omitted pursuant to such rules and regulations. The consolidated balance sheet as of December 31, 2022 derived from the audited consolidated financial statements at that date, but does not include all the information and footnotes required by U.S. GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The unaudited condensed consolidated financial statements as of March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition, results of operations and cash flows. The results of operations for the three months ended March 31, 2023 and 2022 are not necessarily indicative of the results to be expected for any other interim period or for the entire year. Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 － These accompanying unaudited condensed consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying unaudited condensed consolidated financial statements and notes. ● Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the financial statements of AGBA and its subsidiaries. A subsidiary is an entity (including a structured entity), directly or indirectly, controlled by the Company. The financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. All intercompany transactions and balances between AGBA and its subsidiaries are eliminated upon consolidation. ● Use of Estimates and Assumptions The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property and equipment, impairment of long-lived assets, allowance for doubtful accounts, notes receivables, share-based compensation, warrant liabilities, forward share purchase liability, provision for contingent liabilities, revenue recognition, income tax provision, deferred taxes and uncertain tax position, and allocation of expenses from the shareholder. The inputs into the management’s judgments and estimates consider the economic implications of COVID-19 on the Company’s critical and significant accounting estimates. Actual results could differ from these estimates. ● Foreign Currency Translation and Transaction Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations. The reporting currency of the Company is US$ and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company and subsidiaries are operating in Hong Kong maintain their books and record in their local currency, Hong Kong dollars (“HK$”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, Translation of Financial Statement Translation of amounts from HK$ into US$ has been made at the following exchange rates for the three months ended March 31, 2023 and 2022: March 31, March 31, Period-end HK$:US$ exchange rate 0.12739 0.12771 Period average HK$:US$ exchange rate 0.12759 0.12813 ● Cash and Cash Equivalents Cash and cash equivalents consist primarily of cash in readily available checking and saving accounts. They consist of highly liquid investments that are readily convertible to cash and that mature within three months or less from the date of purchase. The carrying amounts approximate fair value due to the short maturities of these instruments. The Company maintains most of its bank accounts in Hong Kong. ● Restricted Cash Restricted cash consist of funds held in escrow accounts reflecting (i) the restricted cash and cash equivalents maintained in certain bank accounts that are held for the exclusive interest of the Company’s customers and (ii) the full obligation to an investor in connection with the Meteora Backstop Agreement (see Note 4). The Company restricts the use of the assets underlying the funds held in escrow to meet with regulatory or contractual requirements and classifies the assets as current based on their purpose and availability to fulfill its direct obligation under current liabilities. ● Accounts Receivable, net Accounts receivable include trade accounts due from customers in insurance brokerage and asset management businesses. Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms. The normal settlement terms of accounts receivable from insurance companies in the provision of brokerage agency services are within 30 days upon the execution of the insurance policies. Credit terms with the products providers of investment, unit and mutual funds and asset portfolio are mainly 90 days or a credit period mutually agreed between the contracting parties. The Company seeks to maintain strict control over its outstanding receivables to minimize credit risk. Overdue balances are reviewed regularly by senior management. Management reviews its receivables on a regular basis to determine if the bad debt allowance is adequate, and provides allowance when necessary. The Company does not hold any collateral or other credit enhancements over its accounts receivable balances. ● Loans Receivables Loans receivables are real estate mortgage loans that carried at unpaid principal balances, less the allowance for credit losses on loans receivables and charge-offs. Loans are placed on nonaccrual status when they are past due 180 days or more as to contractual obligations or when other circumstances indicate that collection is not probable. When a loan is placed on nonaccrual status, any interest accrued but not received is reversed against interest income. Payments received on a nonaccrual loan are either applied to protective advances, the outstanding principal balance or recorded as interest income, depending on an assessment of the ability to collect the loan. A nonaccrual loan may be restored to accrual status when principal and interest payments have been brought current and the loan has performed in accordance with its contractual terms for a reasonable period (generally six months). If the Company determines that a loan is impaired, the Company next determines the amount of the impairment. The amount of impairment on collateral dependent loans is charged off within the given fiscal quarter. Generally, the amount of the loan and negative escrow in excess of the appraised value less estimated selling costs, for the fair value of collateral valuation method, is charged off. For all other loans, impairment is measured as described below in Allowance for Credit Losses on Accounts Receivable and Loans Receivables. ● Allowance for Credit Losses on Accounts and Loans Receivables In accordance with ASC Topic 326 “ Credit Losses – Measurement of Credit Losses on Financial Instruments ● Long-Term Investments, net The Company invests in equity securities with readily determinable fair values and equity securities that do not have readily determinable fair values. Equity securities with readily determinable fair values are carried at fair value with any unrealized gains or losses reported in earnings. Equity securities that do not have readily determinable fair values mainly consist of investments in privately-held companies. They are accounted for, at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. At each reporting period, the Company makes a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. ● Revenue Recognition The Company receives certain portion of its non-interest income from contracts with customers, which are accounted for in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) ASC Topic 606 provided the following overview of how revenue is recognized from the Company’s contracts with customers: The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. Step 1: Identify the contract(s) with a customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price – The transaction price is the amount of consideration in a contract to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer. Step 4: Allocate the transaction price to the performance obligations in the contract – Any entity typically allocates the transaction price to each performance obligation on the basis of the relative standalone selling prices of each distinct good or service promised in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation – An entity recognizes revenue when (or as) it satisfies a performance obligation by transferring a promised good or service to a customer (which is when the customer obtains control of that good or service). The amount of revenue recognized is the amount allocated to the satisfied performance obligation. A performance obligation may be satisfied at a point in time (typically for promises to transfer goods to a customer) or over time (typically for promises to transfer service to a customer). Certain portion of the Company’s income is derived from contracts with customers, and as such, the revenue recognized depicts the transfer of promised goods or services to its customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company considers the terms of the contract and all relevant facts and circumstances when applying this guidance. The Company’s revenue recognition policies are in compliance with ASC Topic 606, as follows: Commissions The Company earns commissions from the sale of investment products to customers. The Company enters into commission agreements with customers which specify the key terms and conditions of the arrangement. Commissions are separately negotiated for each transaction and generally do not include rights of return, credits or discounts, rebates, price protection or other similar privileges, and typically paid on or shortly after the transaction is completed. Upon the purchase of an investment product, the Company earns a commission from customers, calculated as a fixed percentage of the investment products acquired by its customers. The Company defines the “purchase of an investment product” for its revenue recognition purpose as the time when the customers referred by the Company has entered into a subscription contract with the relevant product provider and, if required, the customer has transferred a deposit to an escrow account designated by the Company to complete the purchase of the investment products. After the contract is established, there are no significant judgments made when determining the commission price. Therefore, commissions are recorded at point in time when the investment product is purchased. The Company also facilitates the arrangement between insurance providers and individuals or businesses by providing insurance placement services to the insureds, and is compensated in the form of commissions from the respective insurance providers. The Company primarily facilitates the placement of life, general and MPF insurance products. The Company determines that insurance providers are the customers. The Company primarily earns commission income arising from the facilitation of the placement of an effective insurance policy, which is recognized at a point in time when the performance obligation has been satisfied upon execution of the insurance policy as the Company has no future or ongoing obligation with respect to such policies. The commission fee rate, which is paid by the insurance providers, based on the terms specified in the service contract which are agreed between the Company and insurance providers for each insurance product being facilitated through the Company. The commission earned is equal to a percentage of the premium paid to the insurance provider. Commission from renewed policies is variable consideration and is recognized in subsequent periods when the uncertainty around variable consideration is subsequently resolved (e.g., when customer renews the policy). In accordance with ASC Topic 606, Revenue Recognition: Principal Agent Considerations The Company also offers the sale solicitation of real estate property to the final customers and is compensated in the form of commissions from the corresponding property developers pursuant to the service contracts. Commission income is recognized at a point of time upon the sale contracts of real estate property is signed and executed. Recurring Service Fees The Company provides asset management services to investment funds or investment product providers in exchange for recurring service fees. Recurring service fees are determined based on the types of investment products the Company distributes and are calculated as a fixed percentage of the fair value of the total investment of the investment products, calculated daily. These customer contracts require the Company to provide investment management services, which represents a performance obligation that the Company satisfies over time. After the contract is established, there are no significant judgments made when determining the transaction price. As the Company provides these services throughout the contract term, for the method of calculating recurring service fees, revenue is calculated on a daily basis over the contract term, quarterly billed and recognized. Recurring service agreements do not include rights of return, credits or discounts, rebates, price protection, performance component or other similar privileges and the circumstances under which the fixed percentage fees, before determined, could be not subject to clawback. Payment of recurring service fees are normally on a regular basis (typically monthly or quarterly). Interest Income The Company offers money lending services from loan origination in form of mortgage and personal loans. Interest income is recognized monthly in accordance with their contractual terms and recorded as interest income in the unaudited condensed consolidated statement of operations. The Company does not charge prepayment penalties from its customers. Interest income on mortgage and personal loans is recognized as it accrued using the effective interest method. Accrual of interest income on mortgage loans is suspended at the earlier of the time at which collection of an account becomes doubtful or the account becomes 180 days delinquent. Disaggregation of Revenue The Company has disaggregated its revenue from contracts with customers into categories based on the nature of the revenue. The following table presents the revenue streams by segments, with the presentation revenue categories presented on the unaudited condensed consolidated statements of operations for the periods indicated: For the three months ended March 31, 2023 Distribution Business Platform Business Insurance brokerage service Asset management service Money lending service Real estate agency service Total Interest income:- Loans $ - $ - $ 38,158 $ - $ 38,158 Non-interest income:- Commissions 9,687,819 323,762 - 4,046 10,015,627 Recurring service fees - 1,019,895 - - 1,019,895 $ 9,687,819 $ 1,343,657 $ 38,158 $ 4,046 $ 11,073,680 For the three months ended March 31, 2022 Distribution Business Platform Business Insurance brokerage service Asset management service Money lending service Real estate agency service Total Interest income:- Loans $ - $ - $ 61,323 $ - $ 61,323 Non-interest income:- Commissions 179,931 576,535 - 70,611 827,077 Recurring service fees - 1,187,923 - - 1,187,923 $ 179,931 $ 1,764,458 $ 61,323 $ 70,611 $ 2,076,323 ● Rental Income Rental income represents monthly rental received from the Company’s tenants. The Company recognizes rental income on a straight-line basis over the lease term in accordance with the lease agreement. ● Comprehensive Loss ASC Topic 220, Comprehensive Income ● Income Taxes Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes ASC Topic 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC Topic 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. For the three months ended March 31, 2023 and 2022, the Company did not have any interest and penalties associated with tax positions. As of March 31, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions. The Company is subject to tax in local and foreign jurisdiction. As a result of its business activities, the Company files tax returns that are subject to examination by the relevant tax authorities. ● Share-Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of ASC Topic 718, Stock Compensation ● Net Loss Per Share The Company computes earnings per share (“EPS”) in accordance with ASC Topic 260, Earnings per Share ● Segment Reporting ASC Topic 280, Segment Reporting The Company uses the management approach to determine reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making decisions, allocating resources and assessing performance. The Company’s CODM has been identified as the CEO, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. Based on management’s assessment, the Company determined that it has the following operating segments: Segments Scope of Service Business Activities Distribution Business Insurance Brokerage - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies. Platform Business - Asset Management Business - Providing access to financial products and services to licensed brokers. - Providing operational support for the submission and processing of product applications. - Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc. - Providing training resources and materials. - Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services. - Money Lending Service - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers. - Real Estate Agency Service - Solicitation of real estate sales for the developers, in exchange for commissions. Fintech Business Investment Holding Managing an ensemble of fintech investments. Healthcare Business Investment Holding Managing an ensemble of healthcare-related investments. All of the Company’s revenues were generated in Hong Kong. ● Related Parties The Company follows ASC Topic 850-10, Related Party Pursuant to ASC 850, the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of ASC Topic 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. ● Commitments and Contingencies The Company follows ASC Topic 450-20, Commitments If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. ● Fair Value Measurement The Company follows the guidance of the ASC Topic 820-10, Fair Value Measurements and Disclosures ● Level 1 ● Level 2 : ● Level 3 : Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. The carrying value of the Company’s financial instruments: cash and cash equivalents, restricted cash, accounts receivable, deposit, prepayments and other receivables, amount due to shareholder, accounts payable and accrued liabilities and escrow liabilities approximate at their fair values because of the short-term nature of these financial instruments. Management believes, based on the current market prices or interest rates for similar debt instruments, the fair value of loans receivables and notes receivables approximate the carrying amount. They are accounted at amortised cost, subject to impairment testing. The following table presents information about the Company’s financial assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. March 31, Quoted prices in Significant other Significant other Description 2023 (Level 1) (Level 2) (Level 3) Assets: Marketable equity securities $ 425 $ 425 $ - $ - Non-marketable equity securities $ 34,545,413 $ - $ - $ 34,545,413 Liabilities: Forward share purchase liability $ 13,573,788 $ - $ - $ 13,573,788 Warrant liabilities $ 3,868 $ - $ - $ 3,868 December 31, Quoted prices in Significant other Significant other Description 2022 (Level 1) (Level 2) (Level 3) Assets: Marketable equity securities $ 2,443,593 $ 2,443,593 $ - $ - Non-marketable equity securities $ 34,589,767 $ - $ - $ 34,589,767 Liabilities: Forward share purchase liability $ 13,491,606 $ - $ - $ 13,491,606 Warrant liabilities $ 4,548 $ - $ - $ 4,548 Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates. ● Recently Issued Accounting Pronouncements For the three months ended March 31, 2023, the Company adopted Credit Losses – Measurement of Credit Losses on Financial Instruments for the first time. The adoption of this standard did not have a material impact on the unaudited condensed consolidated financial statements. For further details, please refer to Note 5, 6 and 7. Besides, there were no new standards or updates during the three months ended March 31, 2023 that had a material impact on the unaudited condensed consolidated financial statements.

Liquidity and Going Concern

Liquidity and Going Concern	3 Months Ended
	Mar. 31, 2023
Nature of Business and Basis of Presentation [Abstract]
LIQUIDITY AND GOING CONCERN	NOTE 3 — LIQUIDITY AND GOING CONCERN The accompanying unaudited condensed consolidated financial statements were prepared assuming the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. For the three months ended March 31, 2023, the Company reported $12,072,610 net loss and $10,196,863 net cash outflows from operating activities. As of March 31, 2023, the Company had an accumulated deficit of $51,467,743 and cash and cash equivalents of $3,653,778. The ability to continue as a going concern is dependent on the Company’s ability to successfully implement its plans. The Company believes that it will be able to continue to grow the Company’s revenue base and control expenditures. In parallel, the Company continually monitors its capital structure and operating plans and evaluates various potential funding alternatives that may be needed in order to finance the Company’s business development activities, general and administrative expenses and growth strategy. These alternatives include external borrowings, raising funds through public equity or debt markets. There is no assurance that the Company will be successful with its fundraising initiatives. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties. Without realization of additional capital, there is substantial doubt about the Company can continue as a going concern. However, the Company has obtained adequate and continuing financial support from its major shareholder to meet its debts as they fall due and sustain the operation through the next 12 months from the date that these unaudited condensed consolidated financial statements were made available to issue.

Restricted Cash

Restricted Cash	3 Months Ended
	Mar. 31, 2023
Restricted Cash [Abstract]
RESTRICTED CASH	NOTE 4 — RESTRICTED CASH As of March 31, 2023 and December 31, 2022, the Company had $45.0 million and $44.8 million of restricted cash, respectively, of which (i) $29.5 million (2022: $29.5 million) was held in certain bank accounts on behalf of the Company’s customers and (ii) $15.5 million (2022: $15.3 million) was held in an escrow account in connection with the Meteora Backstop Agreement. For the funds held on behalf of the customers, the Company is acted as a custodian to manage the assets and investment portfolio on behalf of its customers under the terms of certain contractual agreements, which the Company does not have the right to use for any purposes, other than managing the portfolio. Upon receiving escrow funds, the Company records a corresponding escrow liability. Pursuant to the Meteora Backstop Agreement, the fund held in the escrow account for the forward share purchase is restricted to the Company for the nine months following the consummation of the Business Combination in November 2022, unless the investors sells the shares in the market or redeems the shares. Notwithstanding the sale of shares by the investors, the restricted cash will be used to settle any of the Company’s repurchase obligations.

Accounts Receivable, Net

Accounts Receivable, Net	3 Months Ended
	Mar. 31, 2023
Account Receivable [Abstract]
ACCOUNTS RECEIVABLE, NET	NOTE 5 － Accounts receivable, net consisted of the following: As of March 31, December 31, Accounts receivable $ 3,303,401 $ 2,916,609 Accounts receivable – related parties 359,488 272,546 Less: allowance for doubtful accounts (99,991 ) (94,447 ) Accounts receivable, net $ 3,562,898 $ 3,094,708 The accounts receivable due from related parties represented the management service rendered to the portfolio assets of a related companies, which are controlled by the shareholder, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers. The amount is unsecured, interest-free, mutually agreed. The Company generally conducts its business with creditworthy third parties. The Company determines, on a quarterly basis, the probable losses and an allowance for credit losses determined in accordance with the CECL model, based on historical losses, current economic conditions, forecasted future economic and market considerations, and in some cases, evaluating specific customer accounts for risk of loss. Accounts receivable are written off after exhaustive collection efforts occur and the receivable is deemed uncollectible. In addition, receivable balances are monitored on an ongoing basis and its exposure to bad debts is not significant. For the three months ended March 31, 2023 and 2022, the estimated credit losses to accounts receivable were minimal.

Loans Receivables

Loans Receivables	3 Months Ended
	Mar. 31, 2023
Loans Receivables [Abstract]
LOANS RECEIVABLES	NOTE 6 － The Company’s loans receivables portfolio was as follows:- As of March 31, December 31, Mortgage loans $ 1,580,150 $ 1,589,871 Reclassifying as: Current portion $ 517,376 $ 517,479 Non-current portion 1,062,774 1,072,392 Loans receivables, net $ 1,580,150 $ 1,589,871 The interest rates on loans issued ranged between 9.00% and 10.00% per annum for the three months ended March 31, 2023 and 2022. Mortgage loans and secured by collateral in the pledge of the underlying real estate properties owned by the borrowers. Mortgage loans are made to either business or individual customers in Hong Kong for a period of 3 to 25 years, which are fully collateralized and closely monitored for counterparty creditworthiness, with such collateral having a fair value in excess of the carrying amount of the loans as of March 31, 2023 and December 31, 2022. Estimated allowance for credit losses is determined on quarterly basis, in accordance with the CECL model, for general credit risk of the overall portfolio, which is relied on an assessment of specific evidence indicating doubtful collection, historical loss experience, loan balance aging and prevailing economic conditions. If there is an unexpected deterioration of a customer’s financial condition or an unexpected change in economic conditions, including macroeconomic events, the Company will assess the need to adjust the allowance for credit losses. Any such resulting adjustments would affect earnings in the period that adjustments are made. For the three months ended March 31, 2023 and 2022, there were minimal estimated credit losses for loans.

Notes Receivables

Notes Receivables	3 Months Ended
	Mar. 31, 2023
Notes Receivable [Abstract]
NOTES RECEIVABLES	NOTE 7 － On February 24, 2023, the Company entered into a Subscription Agreement and a Convertible Loan Note Instrument (the “Note”) (collectively the “Agreements”) with Investment A. Pursuant to the Agreements, the Company agrees to subscribe an aggregate amount of $1,673,525 notes, in batches, which are payable on or before January 31, 2024 and bears a fixed interest rate of 8% per annum. The maturity of the notes receivables is on April 30, 2024. As of March 31, 2023, the carrying amount of the notes receivables was $588,858. In accordance to ASC Topic 326, the Company accounts for its allowance for credit losses on note receivable using the CECL model. Periodic changes to the allowance for credit losses are recognized in the condensed consolidated statements of operations. For the three months ended March 31, 2023, there were minimal estimated credit losses to notes receivables.

Long-Term Investments, Net

Long-Term Investments, Net	3 Months Ended
	Mar. 31, 2023
Long-Term Investments, Net [Abstract]
LONG-TERM INVESTMENTS, NET	NOTE 8 － Long-term investments consisted of the following: As of Ownership interest March 31, Ownership interest December 31, Marketable equity securities Investment C 0.00 %* $ 425 0.46 % $ 2,443,593 Non-marketable equity securities: Investment A 8.37 % 5,737,714 8.37 % 5,717,678 Investment B 3.63 % 510,263 3.63 % 513,000 Investment D 4.49 % 16,398,730 4.92 % 16,030,943 Investment E 4.00 % 519,769 4.00 % 522,557 Investment F 4.00 % 11,378,937 4.00 % 11,805,589 Total 34,545,413 34,589,767 Net carrying value $ 34,545,838 $ 37,033,360 * less than 0.001% Investments in Marketable Equity Securities Investments in equity securities, such as, marketable securities, are accounted for at its current market value with the changes in fair value recognized in net loss. Investment C was listed and publicly traded on Nasdaq Stock Exchange. During the three months ended March 31, 2023, the Company sold 993,108 shares of Investment C at the average market price of $4.01 per share, resulting with a realized gain of $1,541,736. As of March 31, 2023 and December 31, 2022, Investment C was recorded at fair value of $425 and $2,443,593, which were traded at a closing price of $6.54 and $2.46 per share, respectively. Investments in Non-Marketable Equity Securities Investments in non-marketable equity securities consist of investments in limited liability companies in which the Company’s interests are deemed minor and long-term, strategic investments in companies that are in various stages of development, and investments in a close-ended partnership funds which concentrated in the healthcare sector. These investments do not have readily determinable fair values and, therefore, are reported at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. Management assesses each of these investments on an individual basis, subject to a periodic impairment review and considers qualitative and quantitative factors including the investee’s financial condition, the business outlook for its products and technology, its projected results and cash flow, financing transactions subsequent to the acquisition of the investment, the likelihood of obtaining subsequent rounds of financing and cash usage. When an impairment exists, the investment will be written down to its fair value by recording the corresponding charge as a component of other income (expense), net. Fair value is estimated using the best information available, which may include cash flow projections or other available market data. The following table presents the changes in fair value of non-market equity securities which are measured using Level 3 inputs at March 31, 2023 and December 31, 2022: As of March 31, December 31, Balance at beginning of period/year $ 34,589,767 $ 25,496,534 Additions - 16,228,690 Adjustments: Downward adjustments (427,652) (6,898,549 ) Upward adjustments - 2,137,021 Foreign exchange adjustment 383,298 (2,373,929 ) Balance at end of period/year $ 34,545,413 $ 34,589,767 Cumulative unrealized gains and losses, included in the carrying value of the Company’s non-marketable equity securities: As of March 31, December 31, Downward adjustments (including impairment) $ (27,682,252 ) $ (27,254,600 ) Upward adjustments $ 6,209,357 $ 6,209,357 Investment income is recorded as other income and consisted of the following: For the three months ended March 31, 2023 2022 Marketable equity securities: Unrealized gain from the changes in fair value – Investment C $ 266 $ 2,148,935 Realized gain from sale of Investment C 1,541,736 - Non-marketable equity securities Unrealized losses (including impairment) – Investment F (427,652 ) - Dividend income 608,714 - Investment income, net $ 1,723,064 $ 2,148,935

Borrowings

Borrowings	3 Months Ended
	Mar. 31, 2023
Borrowings [Abstract]
BORROWINGS	NOTE 9 － As of March 31, December 31, Mortgage borrowings $ 6,251,749 $ 4,477,254 In September 2022, the Company obtained a mortgage loan from a finance company in Hong Kong, which bears interest at a fixed rate of 10.85% per annum, is repayable in September 2023. In February 2023, the Company obtained another mortgage loan from another finance company in Hong Kong, which bears an average interest rate at 13.75% per annum, is repayable in February 2024. As of March 31, 2023, the mortgage loans are secured by the office premises of the Company, located in Hong Kong, with the aggregate carrying amount of $7.1 million (December 31, 2022: $5.7 million).

Forward Share Purchase Liabilit

Forward Share Purchase Liability	3 Months Ended
	Mar. 31, 2023
Forward Share Purchase Liabilitiy [Abstract]
FORWARD SHARE PURCHASE LIABILITY	NOTE 10 － The forward share purchase liability (“FSP liability”) under the Meteora Backstop Agreement is valued by an independent valuer using a Black-Scholes model, which is considered to be Level 3 fair value measurement. The following table presents a summary of the changes in fair value of the FSP liability, a Level 3 liability, measured on a recurring basis. Fair value of FSP liability as of December 31, 2022 $ 13,491,606 Change in fair value 82,182 Fair value of FSP liability as of March 31, 2023 $ 13,573,788 For the three months ended March 31, 2023, the change in fair value of FSP liability was $82,182. The following table presents the quantitative information regarding Level 3 fair value measurements of the FSP liability. March 31, December 31, Input Share price $ 1.62 $ 1.54 Risk-free interest rate 3.75 % 4.16 % Volatility 51.46 % 52.19 % Exercise price $ 12.34 $ 12.34 Term 0.38 year 0.61 year

Warrant Liabilities

Warrant Liabilities	3 Months Ended
	Mar. 31, 2023
Warrant Liabilities [Abstract]
WARRANT LIABILITIES	NOTE 11 － The private warrants are accounted for as liabilities in accordance with ASC 480 and are presented as liabilities on the unaudited condensed consolidated balance sheets. As of March 31, 2023 and December 31, 2022, there were 225,000 private warrants outstanding. The fair values of the private warrants are valued by an independent valuer using a Binominal pricing model. The warrants were classified as Level 3 due to the use of unobservable inputs. The key inputs into the Binominal pricing model were as follows at their measurement dates: March 31, December 31, Input Share price $ 1.62 $ 1.54 Risk-free interest rate 3.75 % 4.16 % Volatility 51.46 % 52.19 % Exercise price $ 11.50 $ 11.50 Warrant remaining life 3.38 years 4.9 years As of March 31, 2023 and December 31, 2022, the aggregate value of the private warrants was $3,868 and $4,548, respectively. The changes in fair value for the three months ended March 31, 2023 was $680.

Shareholders_ Equity

Shareholders’ Equity	3 Months Ended
	Mar. 31, 2023
Shareholders’ Equity [Abstract]
SHAREHOLDERS’ EQUITY	NOTE 12 － Ordinary Shares As of March 31, 2023 and December 31, 2022, the Company has authorized share of 200,000,000 ordinary shares with a par value $0.001. On March 2, 2023, pursuant to the Share Award Scheme, the Company issued 1,200,000 ordinary shares to a consultant to compensate the services rendered. On March 21, 2023, the Company issued 2,173,913 ordinary shares to Apex Twinkle Limited as the consideration to partially settle the finder fee payable. As of March 31, 2023 and December 31, 2022, there were 61,750,898 and 58,376,985 ordinary shares issued and outstanding, respectively and 1,665,000 ordinary shares to be issued under the reserve. Public Warrants Each public warrant entitles the holder thereof to purchase one-half (1/2) of one ordinary share at a price of $11.50 per full share, subject to adjustment as discussed herein. The warrants became exercisable 90 days after the Closing of the Business Combination and will expire five years after the Closing of the Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares. This means that only an even number of warrants may be exercised at any given time by a warrant holder. Once the warrants become exercisable, the Company may call the outstanding warrants (including any outstanding warrants issued upon exercise of the unit purchase option issued to Maxim Group LLC) for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption, ● if, and only if, the last sales price of the ordinary shares equals or exceeds $16.50 per share for any 20 trading days within a 30 trading day period ending three business days before the Company send the notice of redemption, and ● if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. If the Company calls the warrants for redemption as described above, the management of the Company will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Whether the Company will exercise our option to require all holders to exercise their warrants on a “cashless basis” will depend on a variety of factors including the price of our ordinary shares at the time the warrants are called for redemption, the Company’s cash needs at such time and concerns regarding dilutive share issuances. Private Warrants The private warrants are identical to the public warrants, except that the private warrants and the ordinary shares issuable upon the exercise of the private warrants were not transferable, assignable or salable until after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the private warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the private warrants are held by someone other than the initial purchasers or their permitted transferees, the private warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants. The private warrants are accounted as liabilities, remeasured to fair value on a recurring basis, with changes in fair value recorded to the condensed consolidated statements of operations (see Note 11). As of March 31, 2023 and December 31, 2022, there were 4,600,000 public warrants and 225,000 private warrants outstanding. Share Award Scheme On February 24, 2023, pursuant to the Share Award Scheme, the Company registered 11,675,397 ordinary shares to be issued. The fair value of the ordinary shares granted under the scheme is measured based on the closing price of the Company’s ordinary shares as reported by Nasdaq Exchange on the date of grant. For those vested immediately on the date of grant, the fair value is recognized as share-based compensation expense in the consolidated statements of operations. During the three months ended March 31, 2023, the Company recorded $2,587,800 share-based compensation expense, which is included in the operating expenses in the unaudited condensed consolidated statements of operations. For the restricted share units (“RSUs”), the fair value is recognized over the period based on the derived service period (usually the vesting period), on a straight-line basis. The valuations assume no dividends will be paid. The Company has assumed 10% forfeitures. As of March 31, 2023, total unrecognized compensation remaining to be recognized in future periods for RSUs totaled $9.8 million. They are expected to be recognized over the weighted average period of 2.7 years. During the three months ended March 31, 2023, the Company recorded $1,317,600 share-based compensation expense, which is included in the operating expenses in the unaudited condensed consolidated statements of operations. A summary of the activities for the Company’s RSUs for the three months ended March 31, 2023 is as follow: For the three months ended Number of RSUs Weighted Average Grant Price Outstanding, beginning of period 5,000,000 $ 2.47 Granted - Vested - Outstanding, end of period 5,000,000 $ 2.47 Forgiveness of Amount Due to Shareholder During the three months ended March 31, 2023, TAG agreed to forgive the Company $3 million, in aggregate, representing certain amount due to it and treat as additional paid-in capital.

Operating Cost and Expenses

Operating Cost and Expenses	3 Months Ended
	Mar. 31, 2023
Operating Cost And Expenses Abstract
OPERATING COST AND EXPENSES	NOTE 13 － OPERATING COST AND EXPENSES Commission expense Pursuant to the terms of respective contracts, commission expense represents certain premiums from insurance or investment products paid to agents. Commission rates vary by market due to local practice, competition, and regulations. The Company charged commission expense on a systematic basis that is consistent with the revenue recognition. During the three months ended March 31, 2023 and 2022, the Company recorded $7,295,492 and $701,042 commission expenses, respectively. Other General and Administrative Expenses The Company incurred different types of expenditures under other general and administrative expenses. They primarily consist of depreciation of property and equipment, legal and professional fees and management fee expenses which are allocated for certain corporate office expenses. During the three months ended March 31, 2023 and 2022, the Company recorded $9,605,190 and $2,004,979 other general and administrative expenses, respectively.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Taxes [Abstract]
INCOME TAXES	NOTE 14 － The provision for income taxes consisted of the following: Three months ended 2023 2022 Current tax $ (26,648 ) $ 64,923 Deferred tax - 354,574 Income tax (benefit) expense $ (26,648 ) $ 419,497 AGBA GROUP HOLDING LIMITED The Company’s subsidiaries mainly operate in Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows: British Virgin Islands The Company is incorporated in the British Virgin Islands and is not subject to taxation. In addition, upon payments of dividends by these entities to their shareholder, no British Virgin Islands withholding tax will be imposed. Hong Kong The Company’s subsidiaries operating in Hong Kong is subject to the Hong Kong profits tax at the income tax rates ranging from 8.25% to 16.5% on the assessable income arising in Hong Kong during its tax year. The following table sets forth the significant components of the deferred tax liabilities and assets of the Company as of March 31, 2023 and December 31, 2022: March 31, December 31, Deferred tax liabilities: Accelerated depreciation $ 45,613 $ 45,858 Deferred tax assets, net: Net operating loss carryforwards 6,854,757 5,461,370 Less: valuation allowance (6,854,757 ) (5,461,370 ) - - Deferred tax liabilities, net $ 45,613 $ 45,858 As of March 31, 2023 and December 31, 2022, the operations incurred $41.5 million and $33.1 million, respectively of cumulative net operating losses which can be carried forward to offset future taxable income. Net operating loss can be carried forward indefinitely but cannot be carried back to prior years. There are no group relief provisions for losses or transfers of assets under Hong Kong tax regime. Each company within a corporate group is taxed as a separate entity. The Company has provided for a full valuation allowance against the deferred tax assets on the expected future tax benefits from the net operating loss carryforwards as the management believes that it is more likely that not all of these assets will be realized in the future. The valuation allowance is reviewed annually. Uncertain tax positions The Company evaluates the uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of March 31, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the three months ended March 31, 2023 and 2022 and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from March 31, 2023.

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2023
Segment Information [Abstract]
SEGMENT INFORMATION	NOTE 15 － ASC Topic 280, Segment Reporting Currently, the Company has four business segments comprised of the related products and services, as follows: Segments Scope of Business Activities Distribution Business Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies. Platform Business - Providing access to financial products and services to licensed brokers; - Providing operational support for the submission and processing of product applications; - Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.; - Providing training resources and materials; - Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services; - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers; and - Solicitation of real estate sales for the developers, in exchange for commissions. Fintech Business Managing an ensemble of fintech investments. Healthcare Business Managing healthcare investments. The four business segments were determined based primarily on how the chief operating decision maker views and evaluates the operations. Operating results are regularly reviewed by the chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance. Other factors, including market separation and customer specific applications, go-to-market channels, products and services are considered in determining the formation of these operating segments. The following tables present the summary information by segment for the three months ended March 31, 2023 and 2022: For the three months ended March 31, 2023 Distribution Business Platform Business Fintech Business Healthcare Business Total Revenue, net - Interest income $ - $ 38,158 $ - $ - $ 38,158 - Non-interest income 9,687,819 1,347,703 - - 11,035,522 9,687,819 1,385,861 - - 11,073,680 Commission expense 6,912,065 383,427 - - 7,295,492 Depreciation 261 95,622 5,289 - 101,172 Income (loss) from operations 452,437 (11,186,637 ) (3,849,608 ) - (14,583,808 ) Investment income, net - - 1,723,064 - 1,723,064 Total assets $ 4,267,591 $ 57,423,358 $ 35,454,721 $ 519,769 $ 97,665,439 For the three months ended March 31, 2022 Distribution Business Platform Business Fintech Business Healthcare Business Total Revenue, net - Interest income $ - $ 61,323 $ - $ - $ 61,323 - Non-interest income 179,931 1,835,069 1,579 - 2,015,000 Less: inter-segment - - (1,579 ) - - 179,931 1,896,392 - - 2,076,323 Commission expense 68,194 632,848 - - 701,042 Depreciation 133 95,943 603 - 96,679 (Loss) income from operations (1,447,062 ) 545,583 (1,010,838 ) - (1,912,317 ) Investment income, net - - 2,148,935 - 2,148,935 Total assets $ 1,571,719 $ 53,922,273 $ 50,338,816 $ 521,053 $ 106,353,861 All of the Company’s customers and operations are based in Hong Kong.

Related Party Balances and Tran

Related Party Balances and Transactions	3 Months Ended
	Mar. 31, 2023
Related Party Balances and Transactions [Abstract]
RELATED PARTY BALANCES AND TRANSACTIONS	NOTE 16 － In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by the shareholder. Amounts represent advances or amounts paid in satisfaction of liabilities. Related party balances consisted of the following: As of March 31, December 31, Accounts receivable (a) $ 359,488 $ 272,546 Amount due to shareholder (b) $ 4,973,844 $ 6,289,743 (a) Accounts receivable due from related parties represented the management service rendered to two individual close-ended investment private funds registered in the Cayman Islands, which is controlled by the shareholder. (b) Amount due to shareholder are those trade and nontrade payables arising from transactions between the Company and the shareholder, such as advances made by the shareholder on behalf of the Company, advances made by the Company on behalf of the shareholder, and allocated shared expenses paid by the shareholder. In the ordinary course of business, during the three months ended March 31, 2023 and 2022, the Company involved with transactions, either at cost or current market prices and on the normal commercial terms among related parties. The following table provides the transactions with these parties for the periods as presented (for the portion of such period that they were considered related): For the three months ended March 31, Nature of transactions 2023 2022 Asset management service income (c) $ 238,933 $ 239,943 Commission expenses (d) $ - $ 48,834 Office and operating fee charge (e) $ 2,029,713 $ 505,146 General and administrative expense allocated (f) $ - $ 273,646 Purchase of office building from the shareholder (g) $ - $ 5,995,249 Payment of special dividends to the shareholder (h) $ - $ 47,000,000 (c) Under the management agreement, the Company shall provide management service to the portfolio assets held by two individual close-ended investment private funds in the Cayman Islands, which is controlled by the Shareholder, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers. (d) Commission fee on insurance brokerage and asset management referral at the predetermined rate based on the service fee. (e) Pursuant to the service agreement, the Company agreed to pay the office and administrative expenses to the shareholder for the use of office premises, including, among other things, building management fees, government rates and rent, office rent, and lease-related interest and depreciation that were actually incurred by the shareholder. Also, the shareholder charged back the reimbursement of legal fee and debt collection fee in the ordinary course of business. (f) Certain amounts of general and administrative expenses were allocated by the shareholder. (g) The Company purchased an office building from the shareholder in January 2022, based on its historical carrying amount. (h) On January 18, 2022, TAG Asia Capital Holdings Limited approved to declare and distribute a special dividend of $47 million to TAG Holdings Limited, the shareholder who represented 1 ordinary share of TAG Asia Capital Holdings Limited. The dividends were paid by offsetting the receivable due from the shareholder and the remaining balance was paid by cash. The special dividend distribution was made due to the investment income from the sale of Nutmeg in September 2021. Apart from the transactions and balances detailed elsewhere in these accompanying unaudited condensed consolidated financial statements, the Company has no other significant or material related party transactions during the periods presented.

Concentrations of Risk

Concentrations of Risk	3 Months Ended
	Mar. 31, 2023
Concentrations of Risk [Abstract]
CONCENTRATIONS OF RISK	NOTE 17 － The Company is exposed to the following concentrations of risk: (a) Major customers For the three months ended March 31, 2023, the customers who accounted for 10% or more of the Company’s revenues and its outstanding receivable balances at period-end dates, are presented as follows: Three months ended March 31, Customer Revenues Percentage of revenues Accounts receivable Customer A $ 2,716,898 25 % $ 1,047,468 Customer B $ 1,370,626 12 % $ 139 Customer C $ 1,231,155 11 % $ 490,058 For the three months ended March 31, 2022, there was no single customer who accounted for 10% or more of the Company’s revenues. All of the Company’s major customers are located in Hong Kong. (b) Credit risk Financial instruments that potentially subject the Company to credit risk consist of cash equivalents, restricted cash, accounts receivable, loans receivables, and notes receivables. Cash equivalents are maintained with high credit quality institutions, the composition and maturities of which are regularly monitored by management. The Hong Kong Deposit Protection Board pays compensation up to a limit of HK$500,000 (approximately $63,695) if the bank with which an individual/a company hold its eligible deposit fails. As of March 31, 2023, cash and cash equivalents of $3.7 million and fund held in escrow of $29.5 million were maintained at financial institutions in Hong Kong, of which approximately $32.2 million was subject to credit risk. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness. For accounts receivable, loans receivables, and notes receivables, the Company determines, on a continuing basis, the probable losses and sets up an allowance for doubtful accounts and loan losses based on the estimated realizable value. Credit of money lending business is controlled by the application of credit approvals, limits and monitoring procedures. The Company uses internally-assigned risk grades to estimate the capability of borrowers to repay the contractual obligations of their loan agreements as scheduled or at all. The Company’s internal risk grade system is based on experiences with similarly graded loans and the assessment of borrower credit quality, such as, credit risk scores, collateral and collection history. Individual credit scores are assessed by credit bureau, such as TransUnion. Internal risk grade ratings reflect the credit quality of the borrower, as well as the value of collateral held as security. To minimize credit risk, the Company requires collateral arrangements to all mortgage loans and has policies and procedures for validating the reasonableness of the collateral valuations on a regular basis. Management believes that these policies effectively manage the credit risk from advances. The Company’s third-party customers that represent more than 10% of total loans receivables, and their related net loans receivables balance as a percentage of total loans receivables, as of March 31, 2022 and December 31, 2021 were as follows: As of March 31, December 31, Customer D 37.4 % 37.4 % Customer E 31.6 % 31.6 % Customer F 31.0 % 31.0 % (c) Economic and political risk The Company’s major operations are conducted in Hong Kong. Accordingly, the political, economic, and legal environments in Hong Kong, as well as the general state of Hong Kong’s economy may influence the Company’s business, financial condition, and results of operations. (d) Exchange rate risk The Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of HKD converted to US$ and Sterling on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice. For the three months ended March 31, 2023 and 2022, the Company recorded the foreign exchange gain of $556,311 and loss of $480,574, respectively, mainly attributable from the long-term investments which are mostly denominated in Sterling. (e) Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company’s policy is to ensure that it has sufficient cash to meet its liabilities when they become due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation. A key risk in managing liquidity is the degree of uncertainty in the cash flow projections. If future cash flows are fairly uncertain, the liquidity risk increases.

Commitments And Contingencies

Commitments And Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 18 － Litigation As at March 31, 2023, the Company involved with various legal proceedings:- Action Case: Action Case: HCA765/2019 Action Case: HCA2097 and 2098/2020 The Company makes a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least each fiscal quarter and adjusted to reflect the impacts of negotiations, estimate settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. Legal fees are expensed in the period in which they are incurred. Forward Share Purchase Agreement Notes Receivable Agreement Capital Contribution in Investment F

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 19 － On April 5, 2023, the Company entered into a sale and purchase agreement with Sony Life Singapore Pte. Ltd., a Singapore private limited company, to purchase 100% equity interest in Sony Life Financial Advisers Pte. Ltd. (“SLFA”) for a cash consideration of SGD2,500,000 (equivalent to $1,882,000). The closing of the transaction expects to be in the third-quarter of 2023, which subjects to certain customary closing conditions. On April 18, 2023, the Company approved a share repurchase program authorizing to purchase up to 1,000,000 ordinary shares at a maximum price of $10 per share from the open market, for a term of one year, no later than April 18, 2024. On April 28, 2023, pursuant to the Share Award Scheme, the Company issued 1,000,000 ordinary shares to a consultant to compensate the services to be rendered in a term of three months. On May 3, 2023, pursuant to the Share Award Scheme, the Company issued 100,000 ordinary shares to a consultant to compensate the services to be rendered in a term of six months. In accordance with ASC Topic 855, Subsequent Events

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation	● Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the financial statements of AGBA and its subsidiaries. A subsidiary is an entity (including a structured entity), directly or indirectly, controlled by the Company. The financial statements of the subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. All intercompany transactions and balances between AGBA and its subsidiaries are eliminated upon consolidation.
Use of Estimates and Assumptions	● Use of Estimates and Assumptions The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include the useful lives of property and equipment, impairment of long-lived assets, allowance for doubtful accounts, notes receivables, share-based compensation, warrant liabilities, forward share purchase liability, provision for contingent liabilities, revenue recognition, income tax provision, deferred taxes and uncertain tax position, and allocation of expenses from the shareholder. The inputs into the management’s judgments and estimates consider the economic implications of COVID-19 on the Company’s critical and significant accounting estimates. Actual results could differ from these estimates.
Foreign Currency Translation and Transaction	● Foreign Currency Translation and Transaction Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the statement of operations. The reporting currency of the Company is US$ and the accompanying unaudited condensed consolidated financial statements have been expressed in US$. In addition, the Company and subsidiaries are operating in Hong Kong maintain their books and record in their local currency, Hong Kong dollars (“HK$”), which is a functional currency as being the primary currency of the economic environment in which their operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, Translation of Financial Statement Translation of amounts from HK$ into US$ has been made at the following exchange rates for the three months ended March 31, 2023 and 2022: March 31, March 31, Period-end HK$:US$ exchange rate 0.12739 0.12771 Period average HK$:US$ exchange rate 0.12759 0.12813
Cash and Cash Equivalents	● Cash and Cash Equivalents Cash and cash equivalents consist primarily of cash in readily available checking and saving accounts. They consist of highly liquid investments that are readily convertible to cash and that mature within three months or less from the date of purchase. The carrying amounts approximate fair value due to the short maturities of these instruments. The Company maintains most of its bank accounts in Hong Kong.
Restricted Cash	● Restricted Cash Restricted cash consist of funds held in escrow accounts reflecting (i) the restricted cash and cash equivalents maintained in certain bank accounts that are held for the exclusive interest of the Company’s customers and (ii) the full obligation to an investor in connection with the Meteora Backstop Agreement (see Note 4). The Company restricts the use of the assets underlying the funds held in escrow to meet with regulatory or contractual requirements and classifies the assets as current based on their purpose and availability to fulfill its direct obligation under current liabilities.
Accounts Receivable, net	● Accounts Receivable, net Accounts receivable include trade accounts due from customers in insurance brokerage and asset management businesses. Accounts receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms. The normal settlement terms of accounts receivable from insurance companies in the provision of brokerage agency services are within 30 days upon the execution of the insurance policies. Credit terms with the products providers of investment, unit and mutual funds and asset portfolio are mainly 90 days or a credit period mutually agreed between the contracting parties. The Company seeks to maintain strict control over its outstanding receivables to minimize credit risk. Overdue balances are reviewed regularly by senior management. Management reviews its receivables on a regular basis to determine if the bad debt allowance is adequate, and provides allowance when necessary. The Company does not hold any collateral or other credit enhancements over its accounts receivable balances.
Loans Receivables	● Loans Receivables Loans receivables are real estate mortgage loans that carried at unpaid principal balances, less the allowance for credit losses on loans receivables and charge-offs. Loans are placed on nonaccrual status when they are past due 180 days or more as to contractual obligations or when other circumstances indicate that collection is not probable. When a loan is placed on nonaccrual status, any interest accrued but not received is reversed against interest income. Payments received on a nonaccrual loan are either applied to protective advances, the outstanding principal balance or recorded as interest income, depending on an assessment of the ability to collect the loan. A nonaccrual loan may be restored to accrual status when principal and interest payments have been brought current and the loan has performed in accordance with its contractual terms for a reasonable period (generally six months). If the Company determines that a loan is impaired, the Company next determines the amount of the impairment. The amount of impairment on collateral dependent loans is charged off within the given fiscal quarter. Generally, the amount of the loan and negative escrow in excess of the appraised value less estimated selling costs, for the fair value of collateral valuation method, is charged off. For all other loans, impairment is measured as described below in Allowance for Credit Losses on Accounts Receivable and Loans Receivables.
Allowance for Credit Losses on Accounts and Loans Receivables	● Allowance for Credit Losses on Accounts and Loans Receivables In accordance with ASC Topic 326 “ Credit Losses – Measurement of Credit Losses on Financial Instruments
Long-Term Investments, net	● Long-Term Investments, net The Company invests in equity securities with readily determinable fair values and equity securities that do not have readily determinable fair values. Equity securities with readily determinable fair values are carried at fair value with any unrealized gains or losses reported in earnings. Equity securities that do not have readily determinable fair values mainly consist of investments in privately-held companies. They are accounted for, at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. At each reporting period, the Company makes a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired.
Revenue Recognition	● Revenue Recognition The Company receives certain portion of its non-interest income from contracts with customers, which are accounted for in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) ASC Topic 606 provided the following overview of how revenue is recognized from the Company’s contracts with customers: The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. Step 1: Identify the contract(s) with a customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price – The transaction price is the amount of consideration in a contract to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer. Step 4: Allocate the transaction price to the performance obligations in the contract – Any entity typically allocates the transaction price to each performance obligation on the basis of the relative standalone selling prices of each distinct good or service promised in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation – An entity recognizes revenue when (or as) it satisfies a performance obligation by transferring a promised good or service to a customer (which is when the customer obtains control of that good or service). The amount of revenue recognized is the amount allocated to the satisfied performance obligation. A performance obligation may be satisfied at a point in time (typically for promises to transfer goods to a customer) or over time (typically for promises to transfer service to a customer). Certain portion of the Company’s income is derived from contracts with customers, and as such, the revenue recognized depicts the transfer of promised goods or services to its customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company considers the terms of the contract and all relevant facts and circumstances when applying this guidance. The Company’s revenue recognition policies are in compliance with ASC Topic 606, as follows: Commissions The Company earns commissions from the sale of investment products to customers. The Company enters into commission agreements with customers which specify the key terms and conditions of the arrangement. Commissions are separately negotiated for each transaction and generally do not include rights of return, credits or discounts, rebates, price protection or other similar privileges, and typically paid on or shortly after the transaction is completed. Upon the purchase of an investment product, the Company earns a commission from customers, calculated as a fixed percentage of the investment products acquired by its customers. The Company defines the “purchase of an investment product” for its revenue recognition purpose as the time when the customers referred by the Company has entered into a subscription contract with the relevant product provider and, if required, the customer has transferred a deposit to an escrow account designated by the Company to complete the purchase of the investment products. After the contract is established, there are no significant judgments made when determining the commission price. Therefore, commissions are recorded at point in time when the investment product is purchased. The Company also facilitates the arrangement between insurance providers and individuals or businesses by providing insurance placement services to the insureds, and is compensated in the form of commissions from the respective insurance providers. The Company primarily facilitates the placement of life, general and MPF insurance products. The Company determines that insurance providers are the customers. The Company primarily earns commission income arising from the facilitation of the placement of an effective insurance policy, which is recognized at a point in time when the performance obligation has been satisfied upon execution of the insurance policy as the Company has no future or ongoing obligation with respect to such policies. The commission fee rate, which is paid by the insurance providers, based on the terms specified in the service contract which are agreed between the Company and insurance providers for each insurance product being facilitated through the Company. The commission earned is equal to a percentage of the premium paid to the insurance provider. Commission from renewed policies is variable consideration and is recognized in subsequent periods when the uncertainty around variable consideration is subsequently resolved (e.g., when customer renews the policy). In accordance with ASC Topic 606, Revenue Recognition: Principal Agent Considerations The Company also offers the sale solicitation of real estate property to the final customers and is compensated in the form of commissions from the corresponding property developers pursuant to the service contracts. Commission income is recognized at a point of time upon the sale contracts of real estate property is signed and executed. Recurring Service Fees The Company provides asset management services to investment funds or investment product providers in exchange for recurring service fees. Recurring service fees are determined based on the types of investment products the Company distributes and are calculated as a fixed percentage of the fair value of the total investment of the investment products, calculated daily. These customer contracts require the Company to provide investment management services, which represents a performance obligation that the Company satisfies over time. After the contract is established, there are no significant judgments made when determining the transaction price. As the Company provides these services throughout the contract term, for the method of calculating recurring service fees, revenue is calculated on a daily basis over the contract term, quarterly billed and recognized. Recurring service agreements do not include rights of return, credits or discounts, rebates, price protection, performance component or other similar privileges and the circumstances under which the fixed percentage fees, before determined, could be not subject to clawback. Payment of recurring service fees are normally on a regular basis (typically monthly or quarterly). Interest Income The Company offers money lending services from loan origination in form of mortgage and personal loans. Interest income is recognized monthly in accordance with their contractual terms and recorded as interest income in the unaudited condensed consolidated statement of operations. The Company does not charge prepayment penalties from its customers. Interest income on mortgage and personal loans is recognized as it accrued using the effective interest method. Accrual of interest income on mortgage loans is suspended at the earlier of the time at which collection of an account becomes doubtful or the account becomes 180 days delinquent. Disaggregation of Revenue The Company has disaggregated its revenue from contracts with customers into categories based on the nature of the revenue. The following table presents the revenue streams by segments, with the presentation revenue categories presented on the unaudited condensed consolidated statements of operations for the periods indicated: For the three months ended March 31, 2023 Distribution Business Platform Business Insurance brokerage service Asset management service Money lending service Real estate agency service Total Interest income:- Loans $ - $ - $ 38,158 $ - $ 38,158 Non-interest income:- Commissions 9,687,819 323,762 - 4,046 10,015,627 Recurring service fees - 1,019,895 - - 1,019,895 $ 9,687,819 $ 1,343,657 $ 38,158 $ 4,046 $ 11,073,680 For the three months ended March 31, 2022 Distribution Business Platform Business Insurance brokerage service Asset management service Money lending service Real estate agency service Total Interest income:- Loans $ - $ - $ 61,323 $ - $ 61,323 Non-interest income:- Commissions 179,931 576,535 - 70,611 827,077 Recurring service fees - 1,187,923 - - 1,187,923 $ 179,931 $ 1,764,458 $ 61,323 $ 70,611 $ 2,076,323
Rental Income	● Rental Income Rental income represents monthly rental received from the Company’s tenants. The Company recognizes rental income on a straight-line basis over the lease term in accordance with the lease agreement.
Comprehensive Loss	● Comprehensive Loss ASC Topic 220, Comprehensive Income
Income Taxes	● Income Taxes Income taxes are determined in accordance with the provisions of ASC Topic 740, Income Taxes ASC Topic 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC Topic 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. For the three months ended March 31, 2023 and 2022, the Company did not have any interest and penalties associated with tax positions. As of March 31, 2023 and December 31, 2022, the Company did not have any significant unrecognized uncertain tax positions. The Company is subject to tax in local and foreign jurisdiction. As a result of its business activities, the Company files tax returns that are subject to examination by the relevant tax authorities.
Share-Based Compensation	● Share-Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of ASC Topic 718, Stock Compensation
Net Loss Per Share	● Net Loss Per Share The Company computes earnings per share (“EPS”) in accordance with ASC Topic 260, Earnings per Share
Segment Reporting	● Segment Reporting ASC Topic 280, Segment Reporting The Company uses the management approach to determine reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker (“CODM”) for making decisions, allocating resources and assessing performance. The Company’s CODM has been identified as the CEO, who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. Based on management’s assessment, the Company determined that it has the following operating segments: Segments Scope of Service Business Activities Distribution Business Insurance Brokerage - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies. Platform Business - Asset Management Business - Providing access to financial products and services to licensed brokers. - Providing operational support for the submission and processing of product applications. - Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc. - Providing training resources and materials. - Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services. - Money Lending Service - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers. - Real Estate Agency Service - Solicitation of real estate sales for the developers, in exchange for commissions. Fintech Business Investment Holding Managing an ensemble of fintech investments. Healthcare Business Investment Holding Managing an ensemble of healthcare-related investments. All of the Company’s revenues were generated in Hong Kong.
Related Parties	● Related Parties The Company follows ASC Topic 850-10, Related Party Pursuant to ASC 850, the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of ASC Topic 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
Commitments and Contingencies	● Commitments and Contingencies The Company follows ASC Topic 450-20, Commitments If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.
Fair Value Measurement	● Fair Value Measurement The Company follows the guidance of the ASC Topic 820-10, Fair Value Measurements and Disclosures ● Level 1 ● Level 2 : ● Level 3 : Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. The carrying value of the Company’s financial instruments: cash and cash equivalents, restricted cash, accounts receivable, deposit, prepayments and other receivables, amount due to shareholder, accounts payable and accrued liabilities and escrow liabilities approximate at their fair values because of the short-term nature of these financial instruments. Management believes, based on the current market prices or interest rates for similar debt instruments, the fair value of loans receivables and notes receivables approximate the carrying amount. They are accounted at amortised cost, subject to impairment testing. The following table presents information about the Company’s financial assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. March 31, Quoted prices in Significant other Significant other Description 2023 (Level 1) (Level 2) (Level 3) Assets: Marketable equity securities $ 425 $ 425 $ - $ - Non-marketable equity securities $ 34,545,413 $ - $ - $ 34,545,413 Liabilities: Forward share purchase liability $ 13,573,788 $ - $ - $ 13,573,788 Warrant liabilities $ 3,868 $ - $ - $ 3,868 December 31, Quoted prices in Significant other Significant other Description 2022 (Level 1) (Level 2) (Level 3) Assets: Marketable equity securities $ 2,443,593 $ 2,443,593 $ - $ - Non-marketable equity securities $ 34,589,767 $ - $ - $ 34,589,767 Liabilities: Forward share purchase liability $ 13,491,606 $ - $ - $ 13,491,606 Warrant liabilities $ 4,548 $ - $ - $ 4,548 Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
Recently Issued Accounting Pronouncements	● Recently Issued Accounting Pronouncements For the three months ended March 31, 2023, the Company adopted Credit Losses – Measurement of Credit Losses on Financial Instruments for the first time. The adoption of this standard did not have a material impact on the unaudited condensed consolidated financial statements. For further details, please refer to Note 5, 6 and 7. Besides, there were no new standards or updates during the three months ended March 31, 2023 that had a material impact on the unaudited condensed consolidated financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Schedule of exchange rates	March 31, March 31, Period-end HK$:US$ exchange rate 0.12739 0.12771 Period average HK$:US$ exchange rate 0.12759 0.12813
Schedule of table presents the revenue streams by segments with the presentation of revenue categories presented on the consolidated statements of operations for the years	For the three months ended March 31, 2023 Distribution Business Platform Business Insurance brokerage service Asset management service Money lending service Real estate agency service Total Interest income:- Loans $ - $ - $ 38,158 $ - $ 38,158 Non-interest income:- Commissions 9,687,819 323,762 - 4,046 10,015,627 Recurring service fees - 1,019,895 - - 1,019,895 $ 9,687,819 $ 1,343,657 $ 38,158 $ 4,046 $ 11,073,680 For the three months ended March 31, 2022 Distribution Business Platform Business Insurance brokerage service Asset management service Money lending service Real estate agency service Total Interest income:- Loans $ - $ - $ 61,323 $ - $ 61,323 Non-interest income:- Commissions 179,931 576,535 - 70,611 827,077 Recurring service fees - 1,187,923 - - 1,187,923 $ 179,931 $ 1,764,458 $ 61,323 $ 70,611 $ 2,076,323
Schedule of company determined that it has the following operating segments	Segments Scope of Service Business Activities Distribution Business Insurance Brokerage - Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies. Platform Business - Asset Management Business - Providing access to financial products and services to licensed brokers. - Providing operational support for the submission and processing of product applications. - Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc. - Providing training resources and materials. - Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services. - Money Lending Service - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers. - Real Estate Agency Service - Solicitation of real estate sales for the developers, in exchange for commissions. Fintech Business Investment Holding Managing an ensemble of fintech investments. Healthcare Business Investment Holding Managing an ensemble of healthcare-related investments.
Schedule of fair value hierarchy of the valuation techniques the company utilized to determine such fair value	March 31, Quoted prices in Significant other Significant other Description 2023 (Level 1) (Level 2) (Level 3) Assets: Marketable equity securities $ 425 $ 425 $ - $ - Non-marketable equity securities $ 34,545,413 $ - $ - $ 34,545,413 Liabilities: Forward share purchase liability $ 13,573,788 $ - $ - $ 13,573,788 Warrant liabilities $ 3,868 $ - $ - $ 3,868 December 31, Quoted prices in Significant other Significant other Description 2022 (Level 1) (Level 2) (Level 3) Assets: Marketable equity securities $ 2,443,593 $ 2,443,593 $ - $ - Non-marketable equity securities $ 34,589,767 $ - $ - $ 34,589,767 Liabilities: Forward share purchase liability $ 13,491,606 $ - $ - $ 13,491,606 Warrant liabilities $ 4,548 $ - $ - $ 4,548

Accounts Receivable, Net (Table

Accounts Receivable, Net (Tables)	3 Months Ended
	Mar. 31, 2023
Account Receivable [Abstract]
Schedule of accounts receivable, net	As of March 31, December 31, Accounts receivable $ 3,303,401 $ 2,916,609 Accounts receivable – related parties 359,488 272,546 Less: allowance for doubtful accounts (99,991 ) (94,447 ) Accounts receivable, net $ 3,562,898 $ 3,094,708

Loans Receivables (Tables)

Loans Receivables (Tables)	3 Months Ended
	Mar. 31, 2023
Loans Receivables [Abstract]
Schedule of loan receivable portfolio	As of March 31, December 31, Mortgage loans $ 1,580,150 $ 1,589,871 Reclassifying as: Current portion $ 517,376 $ 517,479 Non-current portion 1,062,774 1,072,392 Loans receivables, net $ 1,580,150 $ 1,589,871

Long-Term Investments, Net (Tab

Long-Term Investments, Net (Tables)	3 Months Ended
	Mar. 31, 2023
Long-Term Investments, Net [Abstract]
Schedule of long-term investments	As of Ownership interest March 31, Ownership interest December 31, Marketable equity securities Investment C 0.00 %* $ 425 0.46 % $ 2,443,593 Non-marketable equity securities: Investment A 8.37 % 5,737,714 8.37 % 5,717,678 Investment B 3.63 % 510,263 3.63 % 513,000 Investment D 4.49 % 16,398,730 4.92 % 16,030,943 Investment E 4.00 % 519,769 4.00 % 522,557 Investment F 4.00 % 11,378,937 4.00 % 11,805,589 Total 34,545,413 34,589,767 Net carrying value $ 34,545,838 $ 37,033,360
Schedule of changes in fair value of non-marketable equity securities	As of March 31, December 31, Balance at beginning of period/year $ 34,589,767 $ 25,496,534 Additions - 16,228,690 Adjustments: Downward adjustments (427,652) (6,898,549 ) Upward adjustments - 2,137,021 Foreign exchange adjustment 383,298 (2,373,929 ) Balance at end of period/year $ 34,545,413 $ 34,589,767
Schedule of cumulative unrealized gains and losses, included in the carrying value	As of March 31, December 31, Downward adjustments (including impairment) $ (27,682,252 ) $ (27,254,600 ) Upward adjustments $ 6,209,357 $ 6,209,357
Schedule of investment income is recorded as other income	For the three months ended March 31, 2023 2022 Marketable equity securities: Unrealized gain from the changes in fair value – Investment C $ 266 $ 2,148,935 Realized gain from sale of Investment C 1,541,736 - Non-marketable equity securities Unrealized losses (including impairment) – Investment F (427,652 ) - Dividend income 608,714 - Investment income, net $ 1,723,064 $ 2,148,935

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	Mar. 31, 2023
Borrowings [Abstract]
Schedule of borrowings	As of March 31, December 31, Mortgage borrowings $ 6,251,749 $ 4,477,254

Forward Share Purchase Liabil_2

Forward Share Purchase Liability (Tables)	3 Months Ended
	Mar. 31, 2023
Forward Share Purchase Liabilitiy [Abstract]
Schedule of share purchase liability Black-Scholes model	Fair value of FSP liability as of December 31, 2022 $ 13,491,606 Change in fair value 82,182 Fair value of FSP liability as of March 31, 2023 $ 13,573,788
Schedule of level 3 fair value measurements of the FSP liability	March 31, December 31, Input Share price $ 1.62 $ 1.54 Risk-free interest rate 3.75 % 4.16 % Volatility 51.46 % 52.19 % Exercise price $ 12.34 $ 12.34 Term 0.38 year 0.61 year

Warrant Liabilities (Tables)

Warrant Liabilities (Tables)	3 Months Ended
	Mar. 31, 2023
Warrant Liabilities Abstract
Schedule of key inputs into the binominal pricing model	March 31, December 31, Input Share price $ 1.62 $ 1.54 Risk-free interest rate 3.75 % 4.16 % Volatility 51.46 % 52.19 % Exercise price $ 11.50 $ 11.50 Warrant remaining life 3.38 years 4.9 years

Shareholders_ Equity (Tables)

Shareholders’ Equity (Tables)	3 Months Ended
	Mar. 31, 2023
Shareholders’ Equity [Abstract]
Schedule of activities for the company’s RSUs	For the three months ended Number of RSUs Weighted Average Grant Price Outstanding, beginning of period 5,000,000 $ 2.47 Granted - Vested - Outstanding, end of period 5,000,000 $ 2.47

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2023
Income Taxes [Abstract]
Schedule of provision for income taxes	Three months ended 2023 2022 Current tax $ (26,648 ) $ 64,923 Deferred tax - 354,574 Income tax (benefit) expense $ (26,648 ) $ 419,497
Schedule of significant components of the deferred tax liabilities and assets	March 31, December 31, Deferred tax liabilities: Accelerated depreciation $ 45,613 $ 45,858 Deferred tax assets, net: Net operating loss carryforwards 6,854,757 5,461,370 Less: valuation allowance (6,854,757 ) (5,461,370 ) - - Deferred tax liabilities, net $ 45,613 $ 45,858

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Information [Abstract]
Schedule of business segments comprised of the related products and services	Segments Scope of Business Activities Distribution Business Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies. Platform Business - Providing access to financial products and services to licensed brokers; - Providing operational support for the submission and processing of product applications; - Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.; - Providing training resources and materials; - Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services; - Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers; and - Solicitation of real estate sales for the developers, in exchange for commissions. Fintech Business Managing an ensemble of fintech investments. Healthcare Business Managing healthcare investments.
Schedule of information by segment for the years	For the three months ended March 31, 2023 Distribution Business Platform Business Fintech Business Healthcare Business Total Revenue, net - Interest income $ - $ 38,158 $ - $ - $ 38,158 - Non-interest income 9,687,819 1,347,703 - - 11,035,522 9,687,819 1,385,861 - - 11,073,680 Commission expense 6,912,065 383,427 - - 7,295,492 Depreciation 261 95,622 5,289 - 101,172 Income (loss) from operations 452,437 (11,186,637 ) (3,849,608 ) - (14,583,808 ) Investment income, net - - 1,723,064 - 1,723,064 Total assets $ 4,267,591 $ 57,423,358 $ 35,454,721 $ 519,769 $ 97,665,439 For the three months ended March 31, 2022 Distribution Business Platform Business Fintech Business Healthcare Business Total Revenue, net - Interest income $ - $ 61,323 $ - $ - $ 61,323 - Non-interest income 179,931 1,835,069 1,579 - 2,015,000 Less: inter-segment - - (1,579 ) - - 179,931 1,896,392 - - 2,076,323 Commission expense 68,194 632,848 - - 701,042 Depreciation 133 95,943 603 - 96,679 (Loss) income from operations (1,447,062 ) 545,583 (1,010,838 ) - (1,912,317 ) Investment income, net - - 2,148,935 - 2,148,935 Total assets $ 1,571,719 $ 53,922,273 $ 50,338,816 $ 521,053 $ 106,353,861

Related Party Balances and Tr_2

Related Party Balances and Transactions (Tables)	3 Months Ended
	Mar. 31, 2023
Related Party Balances and Transactions [Abstract]
Schedule of related party balances	As of March 31, December 31, Accounts receivable (a) $ 359,488 $ 272,546 Amount due to shareholder (b) $ 4,973,844 $ 6,289,743 (a) Accounts receivable due from related parties represented the management service rendered to two individual close-ended investment private funds registered in the Cayman Islands, which is controlled by the shareholder. (b) Amount due to shareholder are those trade and nontrade payables arising from transactions between the Company and the shareholder, such as advances made by the shareholder on behalf of the Company, advances made by the Company on behalf of the shareholder, and allocated shared expenses paid by the shareholder.
Schedule of ordinary course of business	For the three months ended March 31, Nature of transactions 2023 2022 Asset management service income (c) $ 238,933 $ 239,943 Commission expenses (d) $ - $ 48,834 Office and operating fee charge (e) $ 2,029,713 $ 505,146 General and administrative expense allocated (f) $ - $ 273,646 Purchase of office building from the shareholder (g) $ - $ 5,995,249 Payment of special dividends to the shareholder (h) $ - $ 47,000,000 (c) Under the management agreement, the Company shall provide management service to the portfolio assets held by two individual close-ended investment private funds in the Cayman Islands, which is controlled by the Shareholder, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers. (d) Commission fee on insurance brokerage and asset management referral at the predetermined rate based on the service fee. (e) Pursuant to the service agreement, the Company agreed to pay the office and administrative expenses to the shareholder for the use of office premises, including, among other things, building management fees, government rates and rent, office rent, and lease-related interest and depreciation that were actually incurred by the shareholder. Also, the shareholder charged back the reimbursement of legal fee and debt collection fee in the ordinary course of business. (f) Certain amounts of general and administrative expenses were allocated by the shareholder. (g) The Company purchased an office building from the shareholder in January 2022, based on its historical carrying amount. (h) On January 18, 2022, TAG Asia Capital Holdings Limited approved to declare and distribute a special dividend of $47 million to TAG Holdings Limited, the shareholder who represented 1 ordinary share of TAG Asia Capital Holdings Limited. The dividends were paid by offsetting the receivable due from the shareholder and the remaining balance was paid by cash. The special dividend distribution was made due to the investment income from the sale of Nutmeg in September 2021.

Concentrations of Risk (Tables)

Concentrations of Risk (Tables)	3 Months Ended
	Mar. 31, 2023
Concentrations of Risk [Abstract]
Schedule of revenue and outstanding receivable	Three months ended March 31, Customer Revenues Percentage of revenues Accounts receivable Customer A $ 2,716,898 25 % $ 1,047,468 Customer B $ 1,370,626 12 % $ 139 Customer C $ 1,231,155 11 % $ 490,058
Schedule of related net loans receivable balance as a percentage of total loans receivable	As of March 31, December 31, Customer D 37.4 % 37.4 % Customer E 31.6 % 31.6 % Customer F 31.0 % 31.0 %

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Tax benefit, percentage	50%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of exchange rates - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of exchange rates [Abstract]
Period-end HK$:US$ exchange rate	$ 0.12739	$ 0.12771
Period average HK$:US$ exchange rate	$ 0.12759	$ 0.12813

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of table presents the revenue streams by segments with the presentation of revenue categories presented on the consolidated statements of operations for the years - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting, Revenue Reconciling Item [Line Items]
Distribution Business, Insurance brokerage service	$ 9,687,819	$ 179,931
Platform Business, Asset management service	1,343,657	1,764,458
Platform Business, Money lending service	38,158	61,323
Platform Business, Real estate agency service	4,046	70,611
Total	11,073,680	2,076,323
Recurring service fees [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Distribution Business, Insurance brokerage service
Platform Business, Asset management service	1,019,895	1,187,923
Platform Business, Money lending service
Platform Business, Real estate agency service
Total	1,019,895	1,187,923
Loans [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Distribution Business, Insurance brokerage service
Platform Business, Asset management service
Platform Business, Money lending service	38,158	61,323
Platform Business, Real estate agency service
Total	38,158	61,323
Commissions [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Distribution Business, Insurance brokerage service	9,687,819	179,931
Platform Business, Asset management service	323,762	576,535
Platform Business, Money lending service
Platform Business, Real estate agency service	4,046	70,611
Total	$ 10,015,627	$ 827,077

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of company determined that it has the following operating segments	3 Months Ended
	Mar. 31, 2023
Segment Reporting Information [Line Items]
Scope of Service	Business Activities
Distribution Business [Member]
Segment Reporting Information [Line Items]
Business Activities	- Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
Platform Business [Member]
Segment Reporting Information [Line Items]
Business Activities	- Providing access to financial products and services to licensed brokers. - Providing operational support for the submission and processing of product applications. - Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc. - Providing training resources and materials. - Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services.
Platform Business Two [Member]
Segment Reporting Information [Line Items]
Business Activities	- Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers.
Platform Business Three [Member]
Segment Reporting Information [Line Items]
Business Activities	- Solicitation of real estate sales for the developers, in exchange for commissions.
Fintech Business [Member]
Segment Reporting Information [Line Items]
Business Activities	Managing an ensemble of fintech investments.
Healthcare Business [Member]
Segment Reporting Information [Line Items]
Business Activities	Managing an ensemble of healthcare-related investments.

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details) - Schedule of fair value hierarchy of the valuation techniques the company utilized to determine such fair value - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies (Details) - Schedule of fair value hierarchy of the valuation techniques the company utilized to determine such fair value [Line Items]
Marketable equity securities	$ 425	$ 2,443,593
Non-marketable equity securities	34,545,413	34,589,767
Forward share purchase liability	13,573,788	13,491,606
Warrant liabilities	3,868	4,548
Quoted Prices in Active Markets (Level 1)
Summary of Significant Accounting Policies (Details) - Schedule of fair value hierarchy of the valuation techniques the company utilized to determine such fair value [Line Items]
Marketable equity securities	425	2,443,593
Non-marketable equity securities
Forward share purchase liability
Warrant liabilities
Significant Other Observable Inputs (Level 2)
Summary of Significant Accounting Policies (Details) - Schedule of fair value hierarchy of the valuation techniques the company utilized to determine such fair value [Line Items]
Marketable equity securities
Non-marketable equity securities
Forward share purchase liability
Warrant liabilities
Significant Other Unobservable Inputs (Level 3)
Summary of Significant Accounting Policies (Details) - Schedule of fair value hierarchy of the valuation techniques the company utilized to determine such fair value [Line Items]
Marketable equity securities
Non-marketable equity securities	34,545,413	34,589,767
Forward share purchase liability	13,573,788	13,491,606
Warrant liabilities	$ 3,868	$ 4,548

Liquidity and Going Concern (De

Liquidity and Going Concern (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Nature of Business and Basis of Presentation [Abstract]
Net loss	$ 12,072,610
Net cash outflows from operating activities	10,196,863
Accumulated losses	51,467,743
Cash and cash equivalents	$ 3,653,778	$ 6,449,876

Restricted Cash (Details)

Restricted Cash (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Restricted Cash [Abstract]
Restricted cash	$ 45	$ 44.8
Held in certain account	29.5	29.5
Escrow account	$ 15.5	$ 15.3

Accounts Receivable, Net (Detai

Accounts Receivable, Net (Details) - Schedule of accounts receivable, net - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Schedule of Accounts Receivable Net [Abstract]
Accounts receivable	$ 3,303,401	$ 2,916,609
Accounts receivable – related parties	359,488	272,546
Less: allowance for doubtful accounts	(99,991)	(94,447)
Accounts receivable, net	$ 3,562,898	$ 3,094,708

Loans Receivables (Details)

Loans Receivables (Details)	Mar. 31, 2023	Feb. 28, 2023	Dec. 31, 2022	Mar. 31, 2022
Loans Receivables (Details) [Line Items]
Term loans	3 years
Hong Kong [Member]
Loans Receivables (Details) [Line Items]
Interest rates on loans issued		13.75%
Term loans			25 years
Minimum [Member]
Loans Receivables (Details) [Line Items]
Interest rates on loans issued	9%
Maximum [Member]
Loans Receivables (Details) [Line Items]
Interest rates on loans issued				10%

Loans Receivables (Details) - S

Loans Receivables (Details) - Schedule of loan receivable portfolio - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Loan Portfolio [Abstract]
Mortgage loans	$ 1,580,150	$ 1,589,871
Reclassifying as:
Current portion	517,376	517,479
Non-current portion	1,062,774	1,072,392
Loans receivables, net	$ 1,580,150	$ 1,589,871

Notes Receivables (Details)

Notes Receivables (Details) - USD ($)	Mar. 31, 2023	Feb. 24, 2023
Notes Receivable [Abstract]
Note payable		$ 1,673,525
Fixed interest rate		8%
Note receivable	$ 588,858

Long-Term Investments, Net (Det

Long-Term Investments, Net (Details) - USD ($) $ / shares in Units, shares in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Long-Term Investments, Net [Abstract]
Investment shares	993,108
Per share	$ 4.01
Realized gain (loss)	$ 1,541,736
Fair value	$ 425		$ 2,443,593
Closing price	$ 6.54		$ 2.46

Long-Term Investments, Net (D_2

Long-Term Investments, Net (Details) - Schedule of long-term investments - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Marketable equity securities
Long term investment balance	$ 34,545,413	$ 34,589,767
Net carrying value	$ 34,545,838	$ 37,033,360
Investment C [Member]
Marketable equity securities
Ownership interest	0%	0.46%
Long term investment balance	$ 425	$ 2,443,593
Investment A [Member]
Marketable equity securities
Ownership interest	8.37%	8.37%
Long term investment balance	$ 5,737,714	$ 5,717,678
Investment B [Member]
Marketable equity securities
Ownership interest	3.63%	3.63%
Long term investment balance	$ 510,263	$ 513,000
Investment D [Member]
Marketable equity securities
Ownership interest	4.49%	4.92%
Long term investment balance	$ 16,398,730	$ 16,030,943
Investment E [Member]
Marketable equity securities
Ownership interest	4%	4%
Long term investment balance	$ 519,769	$ 522,557
Investment F [Member]
Marketable equity securities
Ownership interest	4%	4%
Long term investment balance	$ 11,378,937	$ 11,805,589

Long-Term Investments, Net (D_3

Long-Term Investments, Net (Details) - Schedule of changes in fair value of non-marketable equity securities - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Changes in Fair Value of Non Marketable Equity Securities [Abstract]
Balance at beginning of period/year	$ 34,589,767	$ 25,496,534
Additions		16,228,690
Downward adjustments	(427,652)	(6,898,549)
Upward adjustments		2,137,021
Foreign exchange adjustment	383,298	(2,373,929)
Balance at end of period/year	$ 34,545,413	$ 34,589,767

Long-Term Investments, Net (D_4

Long-Term Investments, Net (Details) - Schedule of cumulative unrealized gains and losses, included in the carrying value - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Cumulative Unrealized Gains and Losses Included in the Carrying Value [Abstract]
Downward adjustments (including impairment)	$ (27,682,252)	$ (27,254,600)
Upward adjustments	$ 6,209,357	$ 6,209,357

Long-Term Investments, Net (D_5

Long-Term Investments, Net (Details) - Schedule of investment income is recorded as other income - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of Investment Income is Recorded as Other Income in the Company Consolidated Statements of Operations [Abstract]
Unrealized gain from the changes in fair value – Investment C	$ 266	$ 2,148,935
Realized gain from sale of Investment C	1,541,736
Unrealized losses (including impairment) – Investment F	(427,652)
Dividend income	608,714
Investment income, net	$ 1,723,064	$ 2,148,935

Borrowings (Details)

Borrowings (Details) - USD ($) $ in Millions	Mar. 31, 2023	Feb. 28, 2023	Feb. 24, 2023	Sep. 30, 2022	Mar. 31, 2022
Borrowings (Details) [Line Items]
Annual interest at fixed rate, percentage			8%
Aggregate carrying amount					$ 5.7
Hong Kong [Member]
Borrowings (Details) [Line Items]
Annual interest at fixed rate, percentage				10.85%
Interest rate		13.75%
Aggregate carrying amount	$ 7.1

Borrowings (Details) - Schedule

Borrowings (Details) - Schedule of borrowings - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Schedule of Borrowings [Abstract]
Mortgage borrowings	$ 6,251,749	$ 4,477,254

Forward Share Purchase Liabil_3

Forward Share Purchase Liability (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Forward Share Purchase Liabilitiy [Abstract]
Change in fair value of FSP liability	$ 82,182

Forward Share Purchase Liabil_4

Forward Share Purchase Liability (Details) - Schedule of share purchase liability Black-Scholes model	3 Months Ended
	Mar. 31, 2023 USD ($)
Schedule of Share Purchase Liability Black Scholes Model [Abstract]
Fair value of FSP liability as of December 31, 2022	$ 13,491,606
Change in fair value	82,182
Fair value of FSP liability as of March 31, 2023	$ 13,573,788

Forward Share Purchase Liabil_5

Forward Share Purchase Liability (Details) - Schedule of level 3 fair value measurements of the FSP liability - Level 3 [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Input
Share price	$ 1.62	$ 1.54
Risk-free interest rate	3.75%	4.16%
Volatility	51.46%	52.19%
Exercise price	$ 12.34	$ 12.34
Term	4 months 17 days	7 months 9 days

Warrant Liabilities (Details)

Warrant Liabilities (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Warrant Liabilities (Details) [Line Items]
Aggregate value	$ 3,868
Change in fair value	$ 680
Private Warrants [Member]
Warrant Liabilities (Details) [Line Items]
Warrants outstanding (in Shares)	225,000	225,000
Aggregate value		$ 4,548

Warrant Liabilities (Details) -

Warrant Liabilities (Details) - Schedule of key inputs into the binominal pricing model - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Input
Share price	$ 1.62	$ 1.54
Risk-free interest rate	3.75%	4.16%
Volatility	51.46%	52.19%
Exercise price	$ 11.5	$ 11.5
Warrant remaining life	3 years 4 months 17 days	4 years 10 months 24 days

Shareholders_ Equity (Details)

Shareholders’ Equity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Mar. 21, 2023	Mar. 02, 2023	Feb. 24, 2023
Shareholders’ Equity (Details) [Line Items]
Ordinary shares, authorized	200,000,000	200,000,000
Ordinary shares, par value (in Dollars per share)	$ 0.001	$ 0.001
Ordinary shares, issued				1,200,000
Ordinary shares, issued	61,750,898	58,376,985
Ordinary shares, outstanding	61,750,898	58,376,985
ordinary shares to be issued	1,665,000
Exercisable warrants term	90 days
Expire date	5 years
Description of exercisable warrants	Once the warrants become exercisable, the Company may call the outstanding warrants (including any outstanding warrants issued upon exercise of the unit purchase option issued to Maxim Group LLC) for redemption:  ●in whole and not in part;   ●at a price of $0.01 per warrant;   ●upon a minimum of 30 days’ prior written notice of redemption,   ●if, and only if, the last sales price of the ordinary shares equals or exceeds $16.50 per share for any 20 trading days within a 30 trading day period ending three business days before the Company send the notice of redemption, and   ●if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.
Shares of public warrants	4,600,000
Shares of private warrants outstanding		225,000
					11,675,397
Share-based compensation expense (in Dollars)	$ 2,587,800
Percentage of forfeitures	10%
Recognized in future periods totalled RSUs (in Dollars)	$ 9,800,000
Weighted average period	2 years 8 months 12 days
Share-based compensation expense (in Dollars)	$ 1,317,600
Due to additional paid-in capital (in Dollars)	$ 3,000,000
Public Warrants [Member]
Shareholders’ Equity (Details) [Line Items]
Ordinary share price per share (in Dollars per share)	$ 11.5
Apex Twinkle Limited [Member]
Shareholders’ Equity (Details) [Line Items]
Ordinary shares, issued			2,173,913

Shareholders_ Equity (Details)

Shareholders’ Equity (Details) - Schedule of activities for the company’s RSUs	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Schedule of Activities for the Company RSUs [Abstract]
Number of RSUs, Outstanding, beginning of period	5,000,000
Outstanding, beginning of period (in Dollars per share) | $ / shares	$ 2.47
Number of RSUs, Granted
Number of RSUs, Vested
Number of RSUs, Outstanding, end of period	5,000,000
Weighted Average Grant Price, Outstanding, end of period (in Dollars per share) | $ / shares	$ 2.47

Operating Cost and Expenses (De

Operating Cost and Expenses (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Cost And Expenses Abstract
Commission expenses	$ 7,295,492	$ 701,042
Other general and administrative expenses	$ 9,605,190	$ 2,004,979

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Income Taxes (Details) [Line Items]
Net operating losses	$ 41.5	$ 33.1
Minimum [Member] | Hong Kong [Member]
Income Taxes (Details) [Line Items]
Income tax rate	8.25%
Maximum [Member] | Hong Kong [Member]
Income Taxes (Details) [Line Items]
Income tax rate	16.50%

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of provision for income taxes - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Provision for Income Taxes [Abstract]
Current tax	$ (26,648)	$ 64,923
Deferred tax		354,574
Income tax (benefit) expense	$ (26,648)	$ 419,497

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of significant components of the deferred tax liabilities and assets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Deferred tax liabilities:
Accelerated depreciation	$ 45,613	$ 45,858
Deferred tax assets, net:
Net operating loss carryforwards	6,854,757	5,461,370
Less: valuation allowance	(6,854,757)	(5,461,370)
Deferred tax liabilities, net	$ 45,613	$ 45,858

Segment Information (Details) -

Segment Information (Details) - Schedule of business segments comprised of the related products and services	3 Months Ended
	Mar. 31, 2023
Distribution Business [Member]
Revenue, Major Customer [Line Items]
Distribution Business	Facilitating the placement of insurance to our customers, through licensed brokers, in exchange for initial and ongoing commissions received from insurance companies.
Platform Business [Member]
Revenue, Major Customer [Line Items]
Platform Business	- Providing access to financial products and services to licensed brokers;
Platform Business One [Member]
Revenue, Major Customer [Line Items]
Platform Business	- Providing operational support for the submission and processing of product applications;
Platform Business Two [Member]
Revenue, Major Customer [Line Items]
Platform Business	- Providing supporting tools for commission calculations, customer engagement, sales team management, customer conversion, etc.;
Platform Business Three [Member]
Revenue, Major Customer [Line Items]
Platform Business	- Providing training resources and materials;
Platform Business Four [Member]
Revenue, Major Customer [Line Items]
Platform Business	- Facilitating the placement of investment products for the fund and/or product provider, in exchange for the fund management services;
Hong Kong Money Lender's License [Member]
Revenue, Major Customer [Line Items]
Platform Business	- Providing the lending services whereby the Company makes secured and/or unsecured loans to creditworthy customers; and
International Real Estates [Member]
Revenue, Major Customer [Line Items]
Platform Business	- Solicitation of real estate sales for the developers, in exchange for commissions.
Fintech Business [Member]
Revenue, Major Customer [Line Items]
Fintech Business	Managing an ensemble of fintech investments.
Healthcare Business [Member]
Revenue, Major Customer [Line Items]
Healthcare Business	Managing healthcare investments.

Segment Information (Details)_2

Segment Information (Details) - Schedule of information by segment for the years - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Distribution Business [Member]
Revenue, net
Interest income
Non-interest income	9,687,819	179,931
Total	9,687,819	179,931
Less: inter-segment
Commission expense	6,912,065	68,194
Depreciation	261	133
Income (loss) from operations	452,437	(1,447,062)
Investment income loss net
Total assets	4,267,591	1,571,719
Platform Business [Member]
Revenue, net
Interest income	38,158	61,323
Non-interest income	1,347,703	1,835,069
Total	1,385,861	1,896,392
Less: inter-segment
Commission expense	383,427	632,848
Depreciation	95,622	95,943
Income (loss) from operations	(11,186,637)	545,583
Investment income loss net
Total assets	57,423,358	53,922,273
Fintech Business [Member]
Revenue, net
Interest income
Non-interest income		1,579
Total
Less: inter-segment		(1,579)
Commission expense
Depreciation	5,289	603
Income (loss) from operations	(3,849,608)	(1,010,838)
Investment income loss net	1,723,064	2,148,935
Total assets	35,454,721	50,338,816
Healthcare Business [Member]
Revenue, net
Interest income
Non-interest income
Total
Less: inter-segment
Commission expense
Depreciation
Income (loss) from operations
Investment income loss net
Total assets	519,769	521,053
Total [Member]
Revenue, net
Interest income	38,158	61,323
Non-interest income	11,035,522	2,015,000
Total	11,073,680	2,076,323
Less: inter-segment
Commission expense	7,295,492	701,042
Depreciation	101,172	96,679
Income (loss) from operations	(14,583,808)	(1,912,317)
Investment income loss net	1,723,064	2,148,935
Total assets	$ 97,665,439	$ 106,353,861

Related Party Balances and Tr_3

Related Party Balances and Transactions (Details) $ in Millions	1 Months Ended
	Jan. 18, 2022 USD ($)
Related Party Balances and Transactions [Abstract]
Dividend	$ 47

Related Party Balances and Tr_4

Related Party Balances and Transactions (Details) - Schedule of related party balances - USD ($)		Mar. 31, 2023	Dec. 31, 2022
Schedule of Related Party Balances [Abstract]
Accounts receivable	[1]	$ 359,488	$ 272,546
Amount due to shareholder	[2]	$ 4,973,844	$ 6,289,743
[1]Accounts receivable due from related parties represented the management service rendered to two individual close-ended investment private funds registered in the Cayman Islands, which is controlled by the shareholder.[2]Amount due to shareholder are those trade and nontrade payables arising from transactions between the Company and the shareholder, such as advances made by the shareholder on behalf of the Company, advances made by the Company on behalf of the shareholder, and allocated shared expenses paid by the shareholder.

Related Party Balances and Tr_5

Related Party Balances and Transactions (Details) - Schedule of ordinary course of business - USD ($)		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Schedule of Ordinary Course of Business [Abstract]
Asset management service income	[1]	$ 238,933	$ 239,943
Commission expenses	[2]		48,834
Office and operating fee charge	[3]	2,029,713	505,146
General and administrative expense allocated	[4]		273,646
Purchase of office building from the shareholder	[5]		5,995,249
Payment of special dividends to the shareholder	[6]		$ 47,000,000
[1]Under the management agreement, the Company shall provide management service to the portfolio assets held by two individual close-ended investment private funds in the Cayman Islands, which is controlled by the Shareholder, for a compensation of asset management service fee income at the predetermined rate based on the respective portfolio of asset values invested by the final customers.[2]Commission fee on insurance brokerage and asset management referral at the predetermined rate based on the service fee.[3]Pursuant to the service agreement, the Company agreed to pay the office and administrative expenses to the shareholder for the use of office premises, including, among other things, building management fees, government rates and rent, office rent, and lease-related interest and depreciation that were actually incurred by the shareholder. Also, the shareholder charged back the reimbursement of legal fee and debt collection fee in the ordinary course of business.[4]Certain amounts of general and administrative expenses were allocated by the shareholder.[5]The Company purchased an office building from the shareholder in January 2022, based on its historical carrying amount.[6]On January 18, 2022, TAG Asia Capital Holdings Limited approved to declare and distribute a special dividend of $47 million to TAG Holdings Limited, the shareholder who represented 1 ordinary share of TAG Asia Capital Holdings Limited. The dividends were paid by offsetting the receivable due from the shareholder and the remaining balance was paid by cash. The special dividend distribution was made due to the investment income from the sale of Nutmeg in September 2021.

Concentrations of Risk (Details

Concentrations of Risk (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2023 HKD ($)	Mar. 31, 2022 USD ($)
Concentrations of Risk [Abstract]
Deposit protection	$ 63,695	$ 500,000
Cash and cash equivalents	3,700,000
Fund held in escrow	29,500,000
Maintained financial institutions amount	$ 32,200,000
Combined loans receivables percentage	10%	10%
Foreign exchange gain (loss)	$ 556,311		$ 480,574

Concentrations of Risk (Detai_2

Concentrations of Risk (Details) - Schedule of revenue and outstanding receivable	3 Months Ended
	Mar. 31, 2023
Customer A [Member]
Disaggregation of Revenue [Line Items]
Revenues	$2,716,898
Percentage of revenues	25%
Accounts receivable	$1,047,468
Customer B [Member]
Disaggregation of Revenue [Line Items]
Revenues	$1,370,626
Percentage of revenues	12%
Accounts receivable	$139
Customer C [Member]
Disaggregation of Revenue [Line Items]
Revenues	$1,231,155
Percentage of revenues	11%
Accounts receivable	$490,058

Concentrations of Risk (Detai_3

Concentrations of Risk (Details) - Schedule of related net loans receivable balance as a percentage of total loans receivable	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Customer D [Member]
Concentrations of Risk (Details) - Schedule of related net loans receivable balance as a percentage of total loans receivable [Line Items]
Percentage of total combined loans receivables	37.40%	37.40%
Customer E [Member]
Concentrations of Risk (Details) - Schedule of related net loans receivable balance as a percentage of total loans receivable [Line Items]
Percentage of total combined loans receivables	31.60%	31.60%
Customer F [Member]
Concentrations of Risk (Details) - Schedule of related net loans receivable balance as a percentage of total loans receivable [Line Items]
Percentage of total combined loans receivables	31%	31%

Commitments And Contingencies (

Commitments And Contingencies (Details) $ in Millions			1 Months Ended
	Dec. 15, 2020 USD ($)	Dec. 15, 2020 HKD ($)	Jan. 31, 2024 USD ($)	Mar. 31, 2023 USD ($) shares	Apr. 30, 2019 USD ($)	Apr. 30, 2019 HKD ($)	Dec. 31, 2021 USD ($)
Commitments And Contingencies (Details) [Line Items]
Subscription and claimed damage	$ 1,670,000	$ 13			$ 2,000,000	$ 17
Contingency loss							$ 840,000
Shares outstanding (in Shares) | shares				2,500,000
Shares issued (in Shares) | shares				2,500,000
Shares purchase liability				$ 13,573,788
Committed subscription amount				1,084,439
Capital amount				$ 331,432
Forecast [Member]
Commitments And Contingencies (Details) [Line Items]
Aggregated amount			$ 1,673,525

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Apr. 18, 2023	Apr. 05, 2023	May 03, 2023	Apr. 28, 2023
Subsequent Events (Details) [Line Items]
Equity interest percentage		100%
Ordinary shares price	1,000,000
(in Dollars per share)	$ 10
Open market, term	1 year
Ordinary shares, issued			100,000	1,000,000
SLFA [Member]
Subsequent Events (Details) [Line Items]
Cash equivalent (in Dollars)		$ 500,000
Cash (in Dollars)		$ 1,882,000